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Abstract 
Development of Injectable Hydrogels for Nucleus Pulposus Replacement 
Jonathan D. Thomas 
Anthony M. Lowman 
Michele Marcolongo 
 
 Intervertebral disc degeneration has been reported as the underlying cause for 
75% of cases of lower back pain and is marked by dehydration of the nucleus pulposus 
within the intervertebral disc.  There have been many implant designs to replace the 
nucleus pulposus.  Some researchers have proposed the replacement of the nucleus 
pulposus with hydrogel materials.  The insertion of devices made from these materials 
further compromises the annulus of the disc.  An ideal nucleus replacement could be 
injected into the disc space and form a solid in vivo.  However, injectable replacements 
using curing elastomers and thermoplastic materials are not ideal because of the 
potentially harmful exothermic heat evolved from their reactions and the toxicity of the 
reactants used.   
 We propose a hydrogel system that can be injected as a liquid at 25°C and 
solidified to yield a hydrogel within the intervertebral disc at 37ºC.  In aqueous solutions, 
these polymers have Lower Critical Solution Temperatures (LCST) between 25-37°C, 
making them unique candidate materials for this application. Poly(N-
isopropylacrylamide) (PNIPAAm) is the most widely studied LCST polymer due to its 
drastic transition near body temperature.  However, by itself, pure PNIPAAm forms a 
hydrogel that has low water content and can readily undergo plastic deformation.  To 
increase the water content and impart elasticity to PNIPAAm hydrogels, grafted and 
branched hydrogel systems were created that incorporated the thermogelling PNIPAAm 
and hydrophilic poly(ethylene glycol) (PEG).   
  xv
   In this research, the effects of polymer composition and monomer to initiator 
ratio, which controls polymer MW, on the in vitro swelling properties (mass, chemical, 
and compressive mechanical stability) of hydrogels formed from aqueous solutions of 
these polymers were evaluated.  Immersion studies were also conducted in solutions to 
simulate the osmotic environment of the nucleus pulposus.  The effects of repeated 
compression and unloading cycles on the water content and dimensional recovery of 
hydrogels made from three candidate polymer formulations were also determined.     
 Unlike PNIPAAm and PEG grafted PNIPAAm hydrogels, PEG branched 
hydrogels have covalently linked networks.  Addition of 7 mol% PEG branches to 
PNIPAAm resulted in a hydrogel with a higher water content and better elastic recovery 
than hydrogels made from pure PNIPAAm.  PEG branched PNIPAAm hydrogels were 
shown to have mass, chemical, and compressive mechanical stability in vitro.  
Furthermore, these hydrogels showed superior dimensional recovery after compressive 
cycling than pure PNIPAAm and PEG grafted PNIPAAm hydrogels.  The 7 mol% PEG 
branched PNIPAAm hydrogels have suitable swelling and mechanical properties to 
potentially serve as a nucleus pulposus replacement. 
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1 Introduction 
 Lower back pain is an ailment that affects between 70% and 85% of the US 
population at some point during their lives [1, 2].  It is the second most frequent reason 
for doctor visits in the US behind respiratory infections and the most common cause for 
activity limitation in those under the age of 45 [1].  The direct health care cost associated 
with the treatment of the 65 million Americans who suffer from lower back pain is 
estimated to be $26 billion annually.  The total costs of treatment and related disability 
compensation is estimated to be over $100 billion annually [2].  While the causes of 
lower back pain remain unclear, the majority of cases are thought to be associated with 
degenerative disc disease.   
 The ailment of lower back pain is indiscriminant in that it affects men and women 
at equal rates with most experiencing their first episode of pain between the ages of 30-50 
years [3].  For most individuals, lower back and related sciatic nerve pain only persists 
for a few weeks.  They find conservative treatment options effective in relieving pain.  
Between 60 and 90% of those who suffer from an episode of lower back pain will recover 
within 6-12 weeks [4].  The prospects for patients whose lower back pain persists past 
this period are not good.  Less than half of those who are disabled more than 6 months 
return to work [5].  After 2 years of being disabled with lower back pain, very few return 
to work [5].  Many back pain sufferers are prone to endure episodes of pain throughout 
their lifetime and learn ways by which they can manage and treat their symptoms.  The 
lifetime reoccurrence rates have been reported to be as high as 85% [6].   If conservative 
treatment options fail in addressing pain, surgical options such as discectomy and fusion, 
are considered.  Though these procedures have been shown to relieve pain, they do not 
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restore the natural biomechanical function to the spine.  In addition, both discectomy and 
fusion can potentially accelerate the degeneration of adjacent discs.   
 Hydrogels are three dimensional swellable polymer networks that have a 
consistency similar to that of natural soft tissue.  Implants consisting of hydrogel 
materials have been designed to replace the nucleus pulposus of the disc.  Insertion of 
these swellable polymer networks into the disc space further compromises the 
surrounding annulus layer.  The goal of this project is to create a nucleus pulposus 
replacement that can be injected into in the disc space as a viscous solution and form a 
hydrogel within the disc space.  This thesis will detail the formation of a novel family of 
thermogelling copolymers based on poly(N-isopropylacrylamide) (PNIPAAm) and 
poly(ethylene glycol) (PEG).  The effects of polymer composition and structure upon the 
thermal transitions, in vitro swelling, and mechanical properties of gels formed from 
aqueous solutions of these polymers will be evaluated.  Experiments will be conducted to 
determine the influence that the osmotic environment of the nucleus pulposus might have 
on the hydrogel implant.  The effects of the cyclic compression loading and unloading on 
the water content and dimensional recovery of these hydrogels will also be investigated.   
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2 Background 
2.1 Intervertebral Disc 
2.1.1 Structure and Function of the Disc 
 Human spines consist of 24 vertebral bodies, separated by 23 intervertebral discs.  
The primary role of the intervertebral discs play is to allow motion between the vertebral 
bodies.  The discs also absorb and transfer loads from body to body.  There are 3 sections 
of the spine: cervical, thoracic and lumbar.  Each disc is structurally composed of 3 
separate regions:  vertebral endplates, where the disc contacts each vertebral body, a 
central jelly-like nucleus pulposus, and an outer and more fibrous annulus fibrosis region.  
The annulus fibrosus consists of about 90 layers of laminated collagen fibers [7].  The 
fibers within the layers are oriented at angles of 60° with the spine’s superior/inferior axis 
[8].  Fibers in successive laminae are oriented in alternating directions with respect to the 
spine axis (+60°/-60°/+60°/-60°) [7].    The nucleus and annulus work synergistically to 
transfer loads placed upon the spine.  For example, under axial compression the nucleus 
absorbs the load and transfers stress radially to the layers of annular tissue.   
2.1.2 Biochemistry of the Disc  
The main component of an intervertebral disc is water.  The central nucleus 
pulposus is composed of 70-90% water while the annulus fibrosus contains 60-70% water 
[7-9].  The other major components of the disc are proteoglycans and collagen.   
Collagen accounts for about 50% of the dry weight of the annulus fibrosus and 
20-30% of the dry weight of the nucleus pulposus [10].  The majority of collagen in the 
nucleus is Type II collagen [10].  The annulus contains Type II collagen and about 40% 
Type I collagen.  Type II collagen fibers in the nucleus have been found to have greater 
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intermolecular spacing than Type I collagen.  This enables the nucleus to have a higher 
hydration level and better withstand compressive forces than the annulus [11].   
Proteoglycans are macromolecules that consist of glycosaminoglycan (GAG) 
chains covalently bonded to a protein core [10].  Proteoglycans make up as much as 65% 
of the dry weight of the nucleus [9].  The predominant proteoglycan within the disc is 
aggrecan.  Aggrecan macromolecules are composed of 2 different types of GAG chains 
(keratin sulfate and chondroitin sulfate) that are attached to a protein core [10, 11].  
Within the annulus fibrosus, proteoglycans serve to bind together collagen fibers that are 
found in adjacent laminae [12]. 
Perhaps the most important aspect of GAGs within the disc is their 
polyelectrolytic properties.  GAGs have a fixed negative charge.  The fluid within the 
disc has solutes and ions that have charges, which naturally distribute within the disc to 
achieve electrochemical equilibrium [10].  A net negative charge usually exists because 
there are more negative charges within the disc than in the surrounding tissue [10].  This 
imbalance leads to an osmotic pressure between 0.1-0.3 MPa within the nucleus [13].  A 
substantial amount of fluid is expelled from the disc due to mechanical loading.  This 
fluid, determined to account for 10-20% of the total disc volume over the course of one 
diurnal cycle, re-imbibes into the disc during unloading periods due to the osmotic 
pressure within the nucleus [14, 15]. 
The vertebral endplates, which have an average thickness of 1 mm, prevent the 
nucleus from bulging into the vertebral bodies, as well as absorb loads from the spine 
[16].  The main pathway for nutrient flow into and out of the intervertebral disc is 
through the endplates.  Like the nucleus, the endplates mainly consist of water, collagen, 
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and proteoglycans.  The transport of solutes into and out of the discs is regulated by 
proteoglycans within the endplates [16].   
2.1.3 Mechanical Properties of the Disc 
 The main loading conditions the intervertebral disc experiences are axial 
compression, flexion/extension, lateral bending, and axial rotation.  Under axial 
compression, hydrostatic stresses within the nucleus cause the nucleus to expand in the 
radial direction, resulting in tension in the annulus layers and bulging in the horizontal 
plane.  The tensile loads are highest for the annulus layers adjacent to the nucleus.  For 
bending and torsional loads, the stress states are more complex.  In lateral bending and 
flexion/extension, annulus layers in the direction of the motion are under compression, 
while annulus layers opposite the motion are in tension [17].  The nucleus will move in 
the direction of the tensile forces under lateral bending and flexion/extension motions 
[17].  In the anterior and lateral regions of the annulus, axial torsion results in tensile 
forces in fibers lying in the direction of the axial torque but no stress in fibers lying in the 
opposite direction.  In the posterior annulus region, annular fibers are in tension 
regardless of the torsion direction [8, 17].   
Researchers have utilized many techniques to quantify the mechanical properties 
of the intervertebral disc.  Nachemson was the first to measure the pressure within an 
intervertebral disc in cadavers and then in vivo using a needle equipped with a small 
pressure gauge [18, 19].  His design allowed for measurement of the effects that different 
postures and motions had on the pressure within the disc.  The healthy pressure within the 
nucleus has been shown to be about 0.5 MPa for a L5/S1 disc [20].  The hydrostatic 
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pressures in the disc were found to be 1.3-1.5 times the axial stress subjected to the spinal 
unit [19].  
Some researchers have measured material properties of components of the disc 
[21-25]. Wide variations in the reported values are due to regional difference between 
different sections of a single disc and variations among the techniques to quantify these 
properties [21, 22, 25].  Furthermore, disc properties have been clearly found to be 
dependent on spinal level, age, and degree of degeneration [8, 23].  Tensile moduli of the 
annulus have been reported to be as low as 0.2 MPa and as high as 645 MPa [9, 21].  
Ebara et al. [21] found values ranging from 5 MPa to 50 MPa in their study, observing 
location dependent variations in tensile properties when they tested single annular layers 
from different radial and circumferential positions within the disc.  Similarly, they saw 
variations in failure stress and strain depending on the position within the disc.  Keller et 
al. [22] found a similar pattern of variation in ultimate compressive strength and 
compressive modulus when they tested the properties of vertebral endplates.  Umehara, et 
al. [24] used an indentation technique to find compressive moduli for regions of the 
annulus and nucleus within the intervertebral disc.  The indentation results correlated to 
modulus values that ranged from 5 kPa to 210 kPa [24].  However, indentation tests on 
the fibrous annular layers and fluid-like nucleus are ineffective ways to determine 
modulus values.  Variations in modulus seen with their indentation test are as likely to be 
due to surface variations in the biological tissue.  Indentation testing of fibrous tissue can 
lead to results that are error-prone and cannot be correlated to a compressive modulus.   
Researchers have characterized the mechanical properties of the disc by 
considering the mechanics of a complete functional spinal unit: an intact disc with the 
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adjacent vertebral bodies.  Wilke et al., Steffen et al., and Lysack et al. have designed 
complex spine testing devices to test functional spinal units [26-28].  Wilke et al. 
conducted tests with pure moments and replicated muscular forces with cables [27].  
Steffen et al. studied the effects of asymmetrical loading on intradiscal pressure [28].  He 
used pressure needles inserted within the disc at different locations and determined that 
the highest stresses were occurring in the inner annulus layers in the posterolateral region 
of the disc [28].  Lysack et al. designed a device that tested multi-segment spines 
containing more than one disc.  Their device used an optoelectronic tracking system to 
monitor the motion of the units during loading [26].  In all of these designs, the 
researches used six degrees of freedom load cells to measure 3 forces and 3 moments. 
Mathematical models are useful tools to study the mechanics of the intervertebral 
disc.  It has been assumed that the nucleus is an incompressible, inviscid fluid that has a 
bulk modulus value of 2,200 MPa [29, 30].  However some have assumed that the 
nucleus is a poroelastic solid with a Young’s modulus between 4.5-1,500 kPa and a 
Poisson’s ratio between 0.1 and 0.45 [9, 30].  Models based on such uncertain material 
property assumptions can lead to unreliable results.  Proper validation of mathematical 
models with mechanical tests on function spinal units is required to confirm the models’ 
utility.  Tadano et al. made the observation that stress and strain states in the 
intervertebral disc calculated with a mathematical model, like finite element analysis, are 
highly dependent on the chosen properties of the materials [9].  
Mechanical experiments evaluating the fatigue [31], creep [32-34], and stress 
relaxation [35] properties of the disc have been conducted.  The nucleus of the disc has 
been found to act as a compressible fluid with a time constant of 2-4 hours [36].  This 
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time period is used for the transport of fluid into and out of the disc [33, 37].  Non-linear 
viscoelasticity allows the spinal unit to be highly flexible under low loads and more rigid 
under higher loads [17].  It has been suggested that collagen fibers take up an 
instantaneous load but if a load is applied over a period of time, fluid transport will lead 
to a change in the hydration level of the nucleus [17].  The time dependent creep 
properties of the disc are crucial for withstanding prolonged loads.  Under a constant 
load, the disc will eventually reach a final deformation level.   
2.1.4 Degenerative Disc Disease 
Efficient transfer of stress from the nucleus to the annulus begins to change 
around the age of 30.  The change in mechanical properties of the disc are reflective of 
changes in the concentration and types of proteoglycans in the disc, as well as a 
corresponding loss in the disc’s overall water content [13, 38].  The normal aging process 
causes the water content in the nucleus to fall from a healthy 90% to below 70% [39].  
The distinction between the nucleus and annulus becomes unclear, most likely as a result 
of the increase in collagen content and decreases in the number of proteoglycan side 
chains and aggregates within the nucleus [7, 20].  The vertebral endplates become 
sclerotic and lose their permeability, limiting water and nutrient transport to and from the 
disc.  The transport of metabolic products like lactic acid is slowed causing the disc to 
become more acidic [23, 40].  Frymoyer and Moskowitz [23] put forth that loss of the 
proteoglycan matrix seen with degenerative disc disease is a result of cells within the disc 
dying due to lowered pH levels.   
Nucleus dehydration results in a decrease in the load carried by the nucleus and an 
increase in load on the annulus [40, 41].  In a degenerated spinal unit, stresses are 
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transferred to the outer regions of the vertebral endplates and intervertebral disc [17].  
The disc also loses its capability to attenuate shocks and distribute loads evenly over the 
end plates [42].  Nerves exit the spinal canal through openings called neuroforamina and 
travel to the extremities.  Severe bulging of the disc often accompanies disc degeneration.  
The resulting decrease in disc height is problematic because it leads to a narrowing of the 
nerve root openings and potential buckling in the surrounding ligaments [7, 23, 43].  The 
reduction in space surrounding the nerves is referred to as spinal stenosis [40].  Disc 
height reduction can also cause pain through increased motion because of the laxity of the 
spinal segment. 
With continued degeneration, a portion of the nucleus can penetrate through tears 
or fissures in the annular layers in what is referred to as disc herniation.  The migration of 
nucleus material through the annular layers can cause pain by stimulation of the sinu-
vertebral nerve [17, 40].  The spinal canal and spinal cord are located posterior to the 
intervertebral disc.  The disc is one of the largest avascular structures within the body.  
The disc receives nutrients solely from diffusion transport, mainly through the 
surrounding vertebral endplates rather than through vascularized tissue [36].  Nuclear 
material or the bulge created by the nuclear material can impinge on sensitive nerves 
surrounding the disc and cause pain in the back or lower extremities.  When it was in the 
healthy disc, the nuclear material was avascular.  Herniation brings this avascular tissue 
in contact with vascularized tissue surrounding the disc and this can elicit an 
inflammatory response [40, 41].  The reduction in disc volume leads to instability and, as 
a result, other parts of the spine including the bones, ligaments, and endplates thicken and 
grow to compensate for this instability [40].  Inflammation can also occur at the facet 
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joints, which are located posterior to the discs, due to increased compressive stresses 
resulting from the disc carrying less of the load in the spine [40].     
Within the human lumbar spine, the L4/L5 and L5/S1 discs experience the 
greatest torsional, shear, and compressive loads [23].  Therefore, it is not surprising that 
water loss is also highest in these two levels [13].  As  a results of the high stress states 
found in these discs, approximately 95% of nuclear protrusions occur either at the L4/L5 
and L5/S1 levels [44].  Degeneration has been described as a “cascade” process in which 
vertebral segments adjacent to the diseased disc are placed under increased stresses and 
as a result undergo an accelerated degenerative process [17]. 
2.2 Conservative Treatment Options 
Pain can occur at any point during the degeneration process.  A commonly 
recommended initial treatment for lower back pain is bed rest.  Bed rest is used to treat 
lower back pain because the prone position naturally reduces intradiscal pressure.  
However, in acute conditions, bed rest has been shown to result in no more significant 
pain relief, when compared to a control group having no bed rest [45].  Furthermore, 
prolonged bed rest can lead to muscle atrophy and cardiovascular deconditioning.   
Analgesics, anti-inflammatory drugs, muscle relaxants, sedatives, and 
neurotrophic medications have been used to ease lower back pain.  These drugs are 
therapeutic in that they reduce inflammation and relieve pain, but they do not address the 
deterioration of disc function.  Other conservative treatments that have been used include 
electrotherapy, magnetic fields, ultrasound, chiropractic manipulation, acupuncture, and 
traction.  However, the effectiveness of these treatments is still in question.  Conservative 
treatments do not reverse the degenerative process within the disc.  Their aim is to reduce 
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inflammation stemming from disc material pressing on the nearby nerves.  For up to 33% 
of lower back pain sufferers, conservative treatment options do not sufficiently provide 
pain relief [17].  The only remaining option for these patients suffering from debilitating 
chronic lower back pain is surgery.  
2.3 Surgical Treatments 
2.3.1 Discectomy 
When conservative treatment options are not successful in relieving pain or a risk 
of nerve damage exists, surgical treatment is considered.  Decompression of the 
intervertebral disc can involve cutting away disc, bone, and ligament material that is 
applying pressure to spinal nerves.  Discectomy surgery involves removing herniated disc 
material posteriorly.  This surgery may require removal of a part of the annulus and 
surrounding ligaments [17, 45, 46].  Endoscopic discectomy procedures, which became 
popular in the 1980s, involve the use of X-ray fluoroscopy imaging to remove herniated 
disc material through posterolaterally placed cannulas [47].  Operation through a small 
cannula (4.5-6.0 mm) lessens the damage to the annulus, bone, and ligaments during 
surgery [40].   
Smith proposed the injection of the proteolytic enzyme chymopapain for 
treatment of a herniated nucleus pulposus in 1963 [48].  Injection of chymopapain, which 
is also known as chemonucleolysis, has been shown to have a statistically similar success 
rate to microdiscectomy, open discectomy, and laminectomy  [49, 50].  However, the use 
of chymopapain in the United States has been discontinued due in part to complications 
with anaphylaxis, transverse myelitis, infections, and problems with bleeding [51-55].   
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Ablation of herniated disc material with use of percutaneous laser discectomy was 
first demonstrated by Choy et al. [56].  This method is not widely used due to the effects 
that the increased heat produced by the laser can potentially have on surrounding tissue.  
Using a laser procedure on cervical discs in an in vitro study, Schmolke et al. showed 
their was a potential for thermal damage to the spinal cord and nerve roots [57].  Using 
laser discectomy on an animal model, Turgut et al. found that depth of vaporization from 
the laser could not be completely controlled, resulting in extensive damage to the 
cartilaginous endplates and vertebral bone [58].     
Discectomy reduces pain attributed to disc herniation because it involves removal 
of the disc material that is causing nerve root compression.  From a biomechanical 
standpoint, however, the surgery does not improve the condition of the disc.  Success 
rates have been found to be very unpredictable.  Hanley et al. [59] found that 14% of 
patients experienced disabling lower back pain after an average 38 month follow up 
period post discectomy surgery.  Allen has shown with cadaver lumbar segments that 
nucleotomy resulted in reductions in disc height, intradiscal pressure, and stiffness of the 
lumbar segment [60].  Brinckmann and Grootenboer have reported that loss of disc tissue 
resulted in disc height decrease, increase in annular bulge and a decrease in intradiscal 
pressure on cadaver lumbar discs [61].  Frei et al. reported that nucleotomy of human 
cadaver segments caused a decrease in disc pressure but no significant change in the 
behavior of the disc in shear loading [62].  Discectomy may lead to increased load on 
posterior elements and the increase in annular bulge may cause nerve pain or more shear 
and bending mobility between the adjacent vertebral segments [61].  The cascade process 
continues, often making further surgery necessary.  The revision rates for patient who 
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have discectomy fall between 7 and 15% for patients who have underwent 
microdiscectomy and between 14 and 33% for patients who have underwent 
percutaneous discectomy [63-67].   
2.3.2 Fusion 
Lumbar interbody fusion is a procedure that is performed for sufferers of chronic 
lower back pain stemming from an advanced instability of the intervertebral disc joint.  
This highly invasive surgery involves complete removal of the painful disc and 
replacement with a bone graft.  Posterior fusion is another method used in fusing a spinal 
unit.  It involves the fixation of the posterior facets and lamina, which are located 
posterior to the disc with synthetic materials while leaving the degenerated disc in place.  
Sometimes, posterior fusion is performed in conjunction with interbody fusion.  
Stabilization of the joint by elimination of motion between 2 vertebral bodies leads to 
pain relief for the patient.  Studies show a wide range in success rates of spinal fusion, 
from 32% to 98% [40].  The wide range is in part due to poorly defined definition of 
success after back surgery.  Spinal fusion often leads to newer problems such as bone 
graft donor site pain, pseudoarthosis, and spinal stenosis [68].  Fusing two vertebral 
bodies alters the normal biomechanical properties of the spinal unit by increasing motion 
and stresses on the adjacent intervertebral joints [69].  The degeneration rate may be 
accelerated in adjacent discs due to these increased stresses, creating more instability and 
pain [70].  Highly rigid internal fixation devices have been suspected of causing disuse 
osteoporosis and stress shielding, which can result in muscle atrophy and decrease in 
bone density [69]. 
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2.3.3 Statistics 
In 2000, Bao and Yuan [71] estimated that are almost 700,000 spine procedures 
performed in the United States each year.  Discectomies accounted for about 300,000 of 
spinal procedures in 2005 [72].  Estimates of the number of fusion surgeries in the United 
States each year are between 200,000 and 250,000 [2, 73].  Some totals include counting 
fusions at multiple levels as more than one procedure.   
2.4 Prosthetic Intervertebral Discs 
Problems with the currently available surgical techniques have led researchers to 
investigate the idea of a prosthetic intervertebral disc.  Other joints susceptible to 
degeneration like the hip, knee, and knuckle can be successfully replaced with prosthetic 
devices.  Implants replaced the popular fusion procedures that were once commonly 
performed for diseased knee and hip joints.   
For any prosthetic intervertebral disc design, there are general requirements.  The 
design must involve biocompatible materials that will not cause local tissue reactions, 
carcinogenesis, or organ toxicity [74, 75].  The wear resistance of the materials used in 
the design need to be taken into consideration because wear particles can lead to a foreign 
body response [75].  The fatigue properties of the material need to be sufficient to 
withstand the number of loading cycles to which the intervertebral disc is subjected.  
Ideally, the mechanical properties of a prosthetic intervertebral disc, including stiffness, 
yield and fatigue strength, and viscoelastic properties, should match those of a normal 
healthy disc [74].  Kinematically, the joint should not allow movement that exceeds that 
allowed by a healthy functional spinal unit [74-76].  Finally, the prosthetic disc design 
should allow for safe surgical implantation.   
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2.4.1 Total Disc Replacements 
For discs that have undergone extensive degeneration, removal of the disc and 
replacement with a total disc replacement is an attractive option.  A total disc 
replacement could serve as a preferable treatment to fusion that could allow for 
biomechanical movement between the two adjacent vertebral bodies instead of just a 
rigid fixation.  The benefit of removing both the nucleus and annulus is that the 
effectiveness of a potential surgery would not be susceptible or dependent on the integrity 
of the annulus.  However, total intervertebral discs replacements, which are mostly 
multicomponent designs, are prone to problems such as interfacial bonding and wear 
[71].  Adequate endplate fixation is another major concern that when considering the 
design and clinical use of a total disc replacement.   
2.4.1.1 Metal Spacers 
One of the earliest prosthetic disc designs was developed by Fernstrom and is 
sometimes called the Fernstrom ball [77].  He inserted a stainless steel ball into the 
interbody space in human patients.  X-rays of the Fernstrom disc taken 4-7 years after the 
implantation showed disc space narrowing in 74% of the patients due to subsidence or 
settling of the balls into the vertebral bodies [77].  Fernstrom also observed a patient with 
a Fernstrom disc that migrated into the spinal canal [77].  Knowles developed an all-
metal disc spacer to be placed posteriorly to act as a wedge, taking up the compressive 
load off the posterior elements [78].  The advantage of using an all-metal intervertebral 
device is the fatigue strength of metals.  Spacer devices, such as these, do not restore any 
flexibility to the vertebral unit.  In addition, subsidence is possible because their stiffness 
far exceeds that of a vertebral body. 
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2.4.1.2 Spring Systems 
Hedman and Kostuik [75, 76, 79] have claimed that an effective total disc design 
would have to be able to withstand 100 million cycles, equivalent to 40 years of use.  
This goal for the fatigue life of the implant is appropriate when considering a disc 
replacement because the average patient suffering lower back pain is around 40 years old, 
much younger than the average age of patients requiring hip and knee implants [71].  
Hedman and Kostuik [75, 76, 79] have designed an all-metal disc, that is composed of 
two Ti-6Al-4V (Ti alloy with 6 wt% Al and 4 wt% V) springs placed between either hot 
isotactically pressed or forged CoCrMo endplates with CoCr beads sintered to the 
endplates to ensure fixation with bony ingrowth [75, 76, 79].  The endplates are 
connected with a hinge on the posterior side of the device.  Studies by Schmiedberg et al. 
showed that the device generates wear particles from both the spring/endplate interface 
and hinge/pin interfaces: Ti-6Al-4V wear particles between 1μm to 30μm and CoCrMo 
wear particles between 5μm and 30μm [80].  These particles can elicit a cellular response 
resulting in inflammation or bone resorption.  Bao and Yuan reported that short term 
testing of the Hedman and Kostuik artificial disc made with two Ti-6Al-4V springs in a 
sheep model showed no tissue ingrowth into the springs or hinges [71]. 
Patil designed a disc system composed of cup-shaped metal endplates connected 
by multiple stainless steel springs [81].  The design was to direct stresses away from the 
intervertebral disc with cup-shaped endplates.  Lee et al. [74] suggested that this design 
may present many problems such as wear debris and fatigue failure of the springs.    
Spring system designs such as those proposed by Kostuik and Patil grossly oversimplify 
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spinal motion and are subject to tissue interpenetration that can potentially disrupt 
motion. 
2.4.1.3 SB Charité Disc 
The SB Charité disc was developed by German orthopedic surgeons, Buttner-Janz 
and Schellnack in conjunction with Link®.  It is now manufactured by Johnson and 
Johnson’s DePuy Spine and is the first intervertebral disc replacement to receive FDA 
approval in October, 2004 [82-85].  It has been approved for use at one level in the 
lumbar spine.  The multicomponent device consists of an ultra-high molecular weight 
polyethylene (UHMWPE) sliding core positioned between two CoCrMo endplates and is 
shown in Figure 2.1.  The device does not attempt to mimic a natural disc’s mechanical 
stiffness.   
Over 7000 SB Charité prostheses have been implanted in patients worldwide  
since 1984 [71, 72].  Early clinical tests on the first SB Charité discs showed high 
occurrence of problems such as core or plate dislodgement and core fracturing [36].  
Modifications to the original Charité disc were made to reduce the likelihood of 
dislocation.   Griffith et al. [86] found significant decreases in patient back and leg pain 
following implantation of the disc on an analog scale.  In one clinical study, problems 
with the implant involved fixation at the endplate/implant interface [87].  David [87] 
claims that the SB Charité disc does not match the anatomical nature of the vertebral 
endplates.  In 1996, Cinotti reported 69% of the patients with the prosthesis achieved 
good to excellent results at a minimum 5 year follow up [73].  Lemaire reported in 1997 
that 79% of his patients obtained good results over a 4 year follow up period [73].  
Zeegers reported that 65% of patients showed reduction of low back pain and 64% of the 
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patients showed reduction of leg pain 2 years following implantation with the Charité 
disc [88].  However 12% of the patients in their study required re-operations due to 
complications at the implanted level or other segments [88].  A more recent study by 
McAfee et al. in the United States showed that patients implanted with the Charité disc 
had better functional outcome measures and restoration of disc height when compared to 
a fusion control group [89, 90].  They found the disc was able to maintain normal flexion 
and extension after 2 years following the surgery [90].   
In their study, van Ooij et al. found problems with some of the patients who 
received Charité discs, with complications including anterior subluxation, anterior 
dislocation, abdominal wall hematoma, erection weakness, and in one case retrograde 
ejaculation with loss of libido observed [91].  In some cases, these problems were 
attributed to degeneration of discs at levels other than the implanted disc.   Zindrick et al. 
have criticized the use of the control Bagby and Kuslich (BAK) fusion cages in the 
studies to evaluate the Charité discs claiming that there are currently fusion cages and 
methods available to surgeons for fusion surgery with better success rates than the BAK 
fusion cage [92].  Zindrick et al. also claim that implantation of the Charité disc may 
result in the occurrence or acceleration of adjacent segment degeneration [92].   
The only reported in vivo wear studies for the articulation of the metal endplates 
and polyethylene core have been in a rabbit model over 6 months [92].  Polyethylene 
wear particles generated in UHMWPE artificial hips have been shown to cause 
inflammation and osteolysis and in cases involving similar articulating surfaces.  With 
knees and hip replacements that employ metal/PE interfaces, these complications 
sometimes appear many years after implantation [92, 93].  Retrieved Charité discs have 
  19
shown wear of the polyethylene core [94].  Further evaluation of the wear properties of 
the Charité disc may be warranted.   
2.4.1.4 ProDisc 
Marnay created a 3 piece artificial disc with a design similar to the Charité design 
[73].  The latest design of Marnay’s disc is currently being developed by Synthes Spine 
and is called ProDisc-C or ProDisc-L depending on whether its replacing a cervical or 
lumbar disc [73].  An image of the ProDisc-L is shown in Figure 2.2.  It is composed of 
CoCrMo endplates with a UHMWPE core that snap fits into the inferior end plate.  Each 
CoCrMo endplate is anchored into the vertebral bodies through a central keel, spikes, and 
a porous surface [95].  The major difference between the ProDisc and the Charité disc is 
that the ProDisc design uses only one articulating interface while the Charité uses two.  
This reduces the chances of core dislocation. 
In Europe, the device had been implanted in 6000 patients by 1999 [72].  In 2002, 
Marney reported that 93% of 61 patients implanted with the ProDisc reported satisfaction 
with the outcome [95, 96].  He reported no significant differences between the patients 
who had one vs. two levels of implantation.  In 2001, clinical trials began at 19 centers in 
the United States with surgeries at one or two adjacent levels between L3-S1 [73].  
Instead of using fusion with BAK cages as the control surgery (as in the SB Charité 
studies), these trials used a full front and back fusion using an allograft in the disc space 
and pedicle screws with autograft posteriorly [72].  Initial results from these trials 
indicate that patients who were implanted with the ProDisc had similar Oswestry 
Disability Index scores and visual analog pain scores after 18 months and 30 months to 
the control procedure.  The only major difference between the two groups was patient 
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satisfaction scores, which has been criticized by Zindrick et al. as being an invalid 
measure of an implant [92, 97].  ProDisc-L has been approved by the FDA for disc 
replacement at a single vertebral level [73].       
2.4.1.5 Maverick 
 The current Maverick intervertebral disc replacement (shown in Figure 2.3) is the 
third generation of a design incorporating a two piece CoCrMo ball and socket device 
that allows a more posterior center of rotation [73, 95].  Fixation to the inferior and 
superior endplates is achieved through a keel and porous hydroxyapatite coatings [95].  
Problems with the generation of wear particles such as inflammation and osteolysis are 
not anticipated by the designers of the Maverick as the forces within the disc are 
estimated to be 1/10 that of those of metal on metal ball and socket devices used for the 
hip [95].  They also suggest that the avascular disc environment with no synovial fluid is 
more favorable than the hip or knee environments, where wear particles can absorb and 
transport easily [95].   However, wear particles or ions that are created could possibly 
migrate into the surrounding bone.  No signs of toxicity or problems with macrophage 
production were observed when wear particles from the testing of the Maverick disc were 
evaluated in rabbits [95].  Clinical trials involving a large number of implantations have 
been performed in Europe.  Randomized clinical trials began at a number of centers in the 
United States in 2003 with patients being implanted with Maverick discs at one level 
[73].  These studies are used a lumbar tapered cage fusion device by Medtronic Sofamor 
Danek in conjunction with a BMP soaked Infuse bone graft in a control fusion surgery 
[73, 95].   
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2.4.1.6 Flexicore 
 Spinecore is manufacturing a two piece device composed of a CoCrMo ball and 
socket called Flexicore (Figure 2.4).  The design can be inserted as a single unit 
anteriorly or anterolateraly and allows for manipulation of the implant within the disc 
space [73].  The endplates are dome shaped to match the concavities of the vertebral 
endplates.  Fixation to the endplates is achieved through spikes and titanium plasma spray 
coating on the superior and inferior surfaces.  Range of motion of the device is restricted 
to ±15° in flexion/extension and lateral bending and ±7.5° in axial rotation [95].  Clinical 
trials in the United States began in 2003 with implantation at a single level from L1 to S1 
[95].  A 360° fusion with posterior instrumentation was used as a control surgery in this 
randomized trial [95].      
2.4.1.7 Polymeric Discs  
Researchers have evaluated soft polymeric materials because they have stiffnesses 
similar to that natural disc material.  It is generally believed that better tissue tolerance 
will exist with implant materials that are closer in mechanical properties to the natural 
disc.  A design by Stubstad and Urbaniak [98, 99] consisted of three layers, a silicone 
core sandwiched between two layers of Dacron® mesh embedded silicone.  The purpose 
of the Dacron® covering on the superior and inferior caps was to promote tissue 
ingrowth and implant fixation [98, 99].  The disc was tested in the chimpanzee model, 
where infection and resorption of the adjacent bone was reported [99].  Furthermore, 
dislodgement of the prosthesis occurred if there was not an exact fit [99].  Edeland [100] 
proposed a silicone design that was capped with polyethylene base plates.  Another 
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design by Edeland involved a silicone nucleus design constrained by silicone or 
polyethylene annulus replacements on the bases and outer circumference [101].   
The Acroflex® disc, developed by Steffee in collaboration with Acromed 
Corporation, has been implanted in humans in the United States [101-103].  The implant 
is composed of a hexane-based rubber bonded to two Ti-6Al-4V endplates that are 
sintered with Ti beads [101-103].  Out of six patients who underwent replacement 
surgery with the Acroflex® disc, four had satisfactory results [104, 105].  The two discs 
that failed suffered fractures of the rubber core [104, 105].  The Acroflex® disc was the 
first intervertebral disc prosthesis approved by the FDA to undergo clinical trials under 
the Investigational Device Exemption [94].  However, in 1990, 2-mercaptobenzothiazole, 
a chemical used in the vulcanization process of the rubber core, was found to be 
carcinogenic in rats and clinical use was stopped [104, 105].  A revision of the design of 
the original Acroflex disc, the Acroflex-100, shown in Figure 2.5, is currently being 
investigated by DePuy.  It consists of a silicone elastomer core bonded to two titanium 
endplates [72].  The FDA approved a 13 patient study, however the results have not yet 
been published. 
Another polymeric disc by Lee and Parsons was designed to replace all of the disc 
except for the outermost annular layers [68, 74, 106, 107].  Their composite design was 
composed of a polysiloxane modified styrene-ethylene/butylenes copolymer (C-Flex) 
core to mimic the “softness” of the nucleus [106, 108, 109].  They surrounded the core 
with a stiffer polyurethane reinforced with Dacron fiber lamina to mimic the annulus 
[106, 108, 109].  The stiffer polyurethane endplates were coated with a woven jacket to 
frame the core [106, 108, 109].  The jacket had also been coated with hydroxyapatite to 
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promote bone ingrowth from the vertebral endplates [106, 108, 109].  Bao and Huan have 
claimed that a lack of fixation between the implant and the vertebral bodies is what has 
prevented the Lee device from being tested clinically [71].  A total disc replacement 
designed by Lee consisting of a metal endplates and an polycarbonate polyurethanes is 
currently being developed by Nexgen Spine Inc. [110].   
Ambrosio et al. investigated the potential use of poly(2-
hydroxyethylmethacrylate) / polycaprolactone (PHEMA/PCL) embedded with 
poly(ethylene terephthalate) (PET) fibers [111].  When studied under compression, 
increases in PCL and PET content increased the implants mechanical strength and 
stiffness, which they found to be similar to that of a canine intervertebral disc [111].   
2.4.2 Nucleus Pulposus Replacements 
Researchers began to realize the potential benefits of only replacing the 
dehydrated nucleus while preserving the annulus fibrosus and endplates.  The approach 
could entail a less invasive posterior surgery as well as a return of the annulus to its 
healthy natural tension.  Replacing only the nucleus would not be suitable for cases in 
which the disc is in the later stages of degeneration.  Because these devices are not 
intended to be fixed to the vertebrae, no problems with endplate fixation exist for a 
nucleus replacement.  Also, the surgical time required for a nucleus replacement 
procedure should approach the time required for a discectomy in contrast to the longer 
time required for more invasive complete disc replacements using the prostheses 
described previously [71].   
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2.4.2.1 Hydrogels 
 Hydrogels are 3 dimensional swellable polymer networks that have the ability to 
hold large amounts of water.  They can be tailored to have water contents and 
consistencies similar to those of natural soft tissues, which has made them a class of 
materials of great interest for nucleus pulposus replacement.  In addition, their swelling 
properties could potentially be utilized to make insertion of an artificial nucleus pulposus 
a minimally invasive procedure.    
 Sulzer Spine Tech is developing a polycarbonate urethane (PCU) nucleus 
pulposus replacement called the Newcleus [112].  This material can absorb water up to 
35% of it’s net weight [112].  The implant, which is shown in Figure 2.6, is an elastic 
memory spiral design that allows for easy uncoiling and coiling to facilitate a minimally 
invasive implantation.  Multidirectional fatigue testing has been conducted up to 50 
million cycles with results showing no change in the implant stability [113].  A clinical 
trial in Europe with a small number of patients has shown improvement in Oswestry 
index scores as a result of the surgery with no incidents of extrusion or migration of the 
device [73]. 
2.4.2.1.1 Polyacrylonitrile Based Hydrogels 
In the late 1980s, Ray and Corbin [36, 114-116] designed cylindrical implants to 
be inserted after removal of the nucleus.  They consisted of fiber-woven shells of 
biodegradable poly(glycolic acid) (PGA) that were filled with a thixotropic hydrogel such 
as hyaluronic acid once in positioned during surgery [36, 114-116].  With swelling, the 
shell degraded as tissue was intended to penetrate and grow.  The implants have been 
investigated for controlled release of therapeutic agents such as anti-inflammatory drugs 
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[115].  It was believed that difficulty with sealing the fluid into the capsules caused Ray 
and Corbin to abandon this design [71].   
In the mid 1990s, Ray et al. [117-119] proposed another design that involved side 
by side implants positioned in the medial-lateral position rather than anterior-posterior 
like their earlier design.  Each implant consisted of a polyacrylonitrile (PAN) copolymer 
hydrogel surrounded by flexible but inelastic extended polyethylene fiber [117-119].  
Figure 2.7 shows two of the side by side implants; one with and one without the fiber 
coating.  A potential problem with use of this hydrogel is the leaching of acrylonitrile and 
acrylamide monomers from the hydrogel.  The carcinogenic potential of the implants 
were tested in a mouse model that showed the PAN materials were no more carcinogenic 
than control materials [120].  The implant, which is referred to as the PDN (Prosthetic 
Disc Nucleus), has been tested in fatigue to 50 million cycles with no significant changes 
to the properties of the hydrogel core or PE jacket with fatigue testing[112, 113, 119, 
121].  Bain et al. showed that the PDN devices helped restore the viscoelastic behavior to 
a cadaver disc after nucleotomy and implantation [122].  As of 1991, over 550 patients 
have been implanted with the PDN [114].  Of 423 PDN’s implanted in patients between 
1996-2002, 10% have been explanted, mostly due to extrusion or endplate failure with 
subsidence [112].   
The size of the implant requires a hole to be cut in the annulus larger than the 
incision typically used for discectomy [71].  In one study, it was reported that out of 101 
patients who received the implant, seventeen suffered implant extrusion [71].  One 
potential problem with implants consisting of multiple components is that they are free to 
move around within the area left by the removal of the native nucleus until tissue 
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ingrowth occurs.  Improper positioning of these two swollen devices can change the 
biomechanical behavior.  Their shape characteristics do not ensure that compressive 
stresses on the disc would translate into tensile stresses in the annulus, as in a healthy 
intervertebral disc.  Considering the problems inherent with insertion of 2 PDN devices, 
the investigators of this implant system have tested a single larger device in patients 
called the PDN-SOLO [73].  A clinical follow up study showed that 6 months after 
implantation, 30 patients showed improvement in Oswestry and Prolo scores when 
compared to their preoperative conditions [123].  After 6 months, they also saw no 
evident of device migration, failure, or dislocation in any of the patients [123].  
Neudisc is an implant composed of two grades of hydrolyzed polyacrylonitrile 
(Aquacryl) and polyester mesh that is being developed at Replication Medical, Inc. [113].  
The implant is designed to be implanted in the dehydrated state and hydrated to 80% 
once in position.  The polyester mesh layers within the implant act to resist radial 
deformation or bulging of the implant [124].  Bertagnoli et al. reported that unconfined 
compressive fatigue up to 10 million cycles did not change the hydration level or stiffness 
of the implant 14 days post fatigue [124].  Biocompatibility tests in New Zealand rabbits 
were reported as promising [112].  
2.4.2.1.2 PVA-Based Hydrogels 
Bao and Higham developed a poly(vinyl alcohol) (PVA) nucleus pulposus 
replacement to restore function to the intervertebral disc by mimicking both the 
mechanical and physiological properties of the disc [40, 41, 71, 125-128].  The hydrogel 
material, composed of 70% water, acts similarly to the nucleus in that it absorbs and 
releases water depending on the applied load.  Bao [129] has proposed methods for 
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dehydrating the hydrogel nucleus to facilitate a less invasive insertion into the spine.  Bao 
and Higham have proposed forming a nucleus replacement from two cylindrical 
segments similar to Ray’s design to ease insertion and reduce the size of the hole needed 
in the annulus [125].  A baboon test model of the PVA nucleus showed no adverse local 
or systematic tissue reaction [71].  They report the PVA nucleus substitute to have a 
compressive modulus greater than 4 MPa and a compressive strength greater than 1 MPa 
[128].  Bao and Yuan have also proposed the use of an aperture sealing device to correct 
defects within the annulus due to the introduction of the hydrogel nucleus into the disc 
space [130]. 
Stammen et al. [131] have proposed using PVA hydrogel physically crosslinked 
with freeze-thaw cycling in a number of applications including cartilage replacement and 
spine disc replacement.  They tested the hydrogels in compression and found an increase 
in tangent compressive modulus between 1-18 MPa from 10-60% strain [131].   They 
also found shear tangent modulus in the range of 0.1-0.4 MPa, depending on strain 
magnitude [131]. 
Stryker Spine has been investigating a nucleus replacement made from partially 
dehydrated PVA with a water content of 80% (Aquarelle) [132].  The material has been 
tested in fatigue up to 40 million cycles [112].  The implant requires a 4-5 mm cannula 
for anterior or anterolateral insertion into the disc.  In a baboon model, no evidence of 
systematic or local toxicity was observed for up to 24 months post implantation [132].  A 
33% extrusion rate was observed for anterior implantations and a 20% extrusion rate was 
observed for anterolateral implantations in a baboon model [112, 132].  Some Aquarelle 
nucleus replacements have been implanted into humans in Europe [73]. 
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Prosthetic implants using PVA alone should not be considered stable within the 
physiological environment due to the fact that PVA is a semicrystalline, hydrophilic 
polymer that can undergo dissolution.  The dissolution process involves an unfolding of 
PVA crystal chains that join the amorphous region of the polymer, disentangle, and 
eventually dissolve [133, 134].  Polymer chain dissolution results in a network with a 
decreased mechanical stiffness resulting from a larger network mesh size.  Larger 
crystals, which undergo a slower dissolution process, are found in semicrystalline PVA 
hydrogels that have higher PVA molecular weights [133].    
 Blends of polyvinyl alcohol (PVA) and polyvinyl pyrrolidone (PVP) have been 
investigated by Marcolongo and Lowman [135-138].  They found PVA/PVP hydrogels to 
have enhanced in vitro stability over pure PVA hydrogels [137].  In mechanical testing of 
lumbar anterior column units, they found that implantation of PVA/PVP hydrogels 
restored the compressive stiffness of the spinal unit to its original intact values [136].   
2.4.2.2 Injectable Nucleus Replacements 
Implantation of a pre-formed nucleus implant further compromises the annulus.  
The idea of inserting a dehydrated hydrogel implant and rehydrating once in the disc 
space has potential but is limited by the inability of a surgeon to accurately assess the disc 
cavity that exists and implant the appropriately sized dehydrated hydrogel.  An attractive 
approach to replacing the nucleus is injection of a liquid based compound that will cure 
or harden within the disc space.  This approach would be “space-filling” in that the 
nucleus replacement could potentially fill the disc space completely and fully contact the 
surrounding annulus tissue.  This has been shown to be a key requirement for a nucleus 
replacement’s ability to restore healthy tension to the annulus layers [139].  Furthermore, 
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an injectable design is advantageous because it allows for a minimally invasive surgery 
where the condition and stability of the annulus are not further compromised with 
implantation of the device.   
The first attempts at an injectable nucleus replacement were made in 1955 by 
David Cleveland who injected methyl-acrylic into the disc spaces of 14 patients 
undergoing discectomy [73, 113].  In the late 1950s, Nachemson injected a curing liquid 
silicone rubber into cadaver discs but found degradation in the implants after 20-30 
thousand compression cycles that mimicked a walking load [140].  Froning experimented 
with designs involving fluid filled bladders to more closely mimic the fluid like 
properties of the nucleus [141].  There have been numerous proposals involving fluid 
filled bladders [140].  However, these designs pose the problem of critical rupture, as 
seen with breast implants, and therefore may not be suitable nucleus prostheses.  
Furthermore, a fluid filled bladder does not mimic the biomechanics of the disc.   
Garcia showed that a polyurethane elastomer can be polymerized in situ within a 
nucleus cavity at physiological temperatures rather than at the traditional processing 
temperature of 100°C [142].  Felt et al. [143, 144] have investigated a disc design 
involving the injection of curing polyurethane in situ in conjunction with a balloon 
catheter and delivery balloon.  Their design was tested with a human cadaver model and 
showed that the device is able to restore disc height and disc modulus.  Millan et. al. 
[145] have proposed injection of a oligomers such as isocyanate or silane functionalized 
prepolymers that would crosslink with exposure to moisture.  The DASCOR Disc 
Arthroplasty Device is being investigated by Disc Dynamics, Inc.  The DASCOR implant 
involves the injection of a fast curing polyurethane into a polyurethane balloon that are 
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introduced to the disc space through a catheter [73, 112].  The use of a balloon reduces 
the chance of curing liquid reactants from leaching out of the disc space through annular 
defects.  It is currently being evaluated in animal studies and enrollment for clinical trials 
in Europe have begun [73].  Disc Augmentation Technologies has proposed the injection 
of a heated thermoplastic that would harden after it cools within the disc space [73].   
The risk of injection of a heated thermoplastic to the disc space is a localized 
heating of surrounding tissue.  This also is a concern with in situ polymerizations as they 
are exothermic processes.  Use of in situ curing formulations is a major concern because 
they involve monomer, short chain oligomers, initiators and/or catalysts that in many 
cases are toxic and carcinogenic.  Furthermore, injection pressure needs to be closely 
monitored to make sure the nuclear cavity is filled and that the monomer and oligomer 
solution doesn’t herniate through fissures in the annulus prior to curing.   
Cryolife has developed the BioDisc nucleus replacement, which involves the 
minimally invasive injection of a protein hydrogel solution that hydrogels within a few 
minutes once in the disc space [73, 112].  The solidification of the protein hydrogel has 
been described as a “crosslinking” however it is not clear weather the crosslinks formed 
upon injection are of a chemical or physical nature. Fatigue studies using the BioDisc in 
the calf spine model showed that implant restored the disc height of a de-nucleated disc 
and remained stable and intact within the disc environment after withstanding 10 million 
cycles [146].   
2.5 Other Approaches 
Some have looked for tissue engineering solutions to replace the intervertebral 
disc.  The major hurdle that makes this approach challenging is the avascular nature of 
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the nucleus region of the intervertebral disc.  Cell migration, adhesion and growth onto a 
scaffold are not likely to occur in a nuclear cavity that is devoid of vascularized tissue.  In 
addition, the cells found within the nucleus pulposus are mostly quiescent or nondividing 
[147].  
Stone has attempted to regenerate the intervertebral disc by constructing a 
scaffold of biocompatible and bioresorbable glycosaminoglycan fibers [148].  Their aim 
is to have cells penetrate and grow into the scaffold as the scaffold dissolves within the 
body.  A tissue engineering approach to repairing the intervertebral disc has also been 
developed by Gan et al.  They implanted nucleus pulposus cells onto PLGA (polylactide-
co-glycolide) and bioactive glass substrates [149-151].  Their results showed that both the 
PLGA and bioactive glass substrates had cell adhesion and proliferation.  The bioactive 
glass with a calcium phosphate rich layer was found to induce cellular activity much 
better than the PLGA [149].   
Recently, Mizuno et al. have investigated a composite tissue-engineered 
intervertebral disc [152].  Annulus fibrosus and nucleus pulposus cells  were obtained 
from sheep discs and seeded on scaffold constructed of PGA/PLA [152].  Sixteen weeks 
after subcutaneous implantation in mice, the mechanical stiffness of the constructs were 
found to be between the values obtained for annulus and nucleus tissue tested with a 
similar technique [152].   
Introduction of mitogens and chondrogenic morphogens such as insulin growth 
factor-1 (IGF-1), epidermal growth factor (EGF), fibroblast growth factor (FGF), 
transforming growth factor (TGF-ß), and bone morphogenetic proteins (BMP) have been 
proposed as ways to retard or reverse the degeneration within the nucleus pulposus.  
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Thompson et al. have shown that the in vitro introduction of TGF-ß1 to canine 
intervertebral disc tissue stimulated an increase in proteoglycan synthesis [153-155].  
Takegamie et al. showed Osteogenic protein-1 (OP-1) could lead to proteoglycan 
synthesis and recovery of proteoglycan content after the introduction of an inflammatory 
agent [154].  The introduction of exogenous growth factors has shown some promising 
results but inherently these therapies are limited by the short half-lives during which 
these factors remain bioactive.  Another method that has been investigated is inhibiting 
the catabolic enzymes (most notably matrix metalloproteinases (MMPs)) that are present 
within the disc during matrix degradation [147].     
Gene therapy approaches to halting and reversing the degradation of the 
intervertebral disc have been proposed and investigated.  The most investigated and 
feasible approach is introduction of genes to target cells so that they restore production of 
proteins such as proteoglycans or collagen.  The most attractive strategy for 
accomplishing this is through the in vivo introduction of genes in viral vectors [147].  
Since the intervertebral disc is highly avascular, the problems that have been classically 
associated with viral gene therapy such as immuno-response should be minimized.  
Adenoviral vectors (as opposed to retroviral) are more likely options as they are able to 
infect many types of cells, including quiescent, nondividing cells like those found in the 
nucleus pulposus.  Paul et al. showed that Sox9 delivery by adenovirus increased disc cell 
production and the production of type II collagen in vivo and prevented degenerative 
changes within a rabbit annulus puncture model [156].  Before gene therapy is used 
clinically, the regulation of transgene expression after gene transfer needs to be further 
understood.  Administration of doses of a gene above the therapeutic level have been 
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shown to cause many problems in rabbits [154].  Furthermore, any gene therapy solutions 
to disc degeneration must be carefully administered considering the proximity of the disc 
to nerves and the spinal cord.   
2.6 Poly(N-isopropylacrylamide) 
2.6.1 Lower Critical Solution Temperature 
 The phase diagrams of most polymer-solvent systems are represented by the 
schematic in  Figure 2.8a.  At lower temperatures, the polymer is immiscible in the 
solvent.  As the temperature of the polymer-solvent is raised, the mixture can pass a 
spinodal line and form a metastable phase of miscibility.  The temperature can be raised 
further to reach the binodal, which represents the line obtained by solving the equations 
for chemical potential.  Above the binodal, the polymer is miscible in the solvent.  The 
binodal and spinodal lines meet at the apex of each line and the temperature 
corresponding to this point is referred to as the upper critical solution temperature 
(UCST).  A polymer solution having a composition that corresponds with this point can 
pass directly from a single phase to a two-phase system or vice-versa without the 
formation of a metastable phase [157].   
 Freeman and Rowlinson studied polyisobutylene in non-polar solvents and were 
the first to report (1959) the behavior of polymers that exhibit a lower critical solution 
temperature (LCST) [158].  The phase diagram of systems that exhibit an LCST is 
represented in Figure 2.8b.  At lower temperatures, the polymer is miscible in a solvent 
but forms metastable and stable two phase systems when the temperature is raised.  
There’s an upward concavity of the spinodal and binodal with LCST systems while 
UCST systems have a downward concavity.  The schematic in Figure 2.8b shows an 
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exaggerated concavity for illustrative purposes.  Accurate phase diagrams of these LCST 
systems have binodal lines that are highly flattened.  The existence of LCSTs can not be 
explained by the Flory–Huggins model because their origin are due to factors that are not 
contained within the theory of polymer solution behavior due to assumptions that it 
makes [157].  One of the many aspects that it does not account for are strong specific 
interactions that can occur in systems.    
 Poly(N-isopropylacrylamide) (PNIPAAm) is a polymer that exhibits an LCST in 
aqueous solutions.  The chemical structure of a PNIPAAm repeat unit is found in Figure 
2.9.  This polymer is perhaps the most studied LCST system due to its drastic transition 
and the fact that its LCST falls between 32-34°C.  The proximity of PNIPAAm’s LCST 
to body temperature has made it a well researched polymer for biomedical applications.   
 The LCST of PNIPAAm systems is due to a balance between hydrophobic and 
hydrophilic forces [159, 160].  Below the LCST of PNIPAAm, Hydrogen bonding 
interactions between water molecules and amide groups (-NH and –C=O) dominate, 
causing the polymer to be miscible in water.  Once the temperature of the solution is 
raised above the LCST, hydrophobic interactions between the isopropyl groups (HC-
(CH3)2) dominate, water is expelled from the polymer structure, and results in the 
precipitation of the polymer.   
 The LCST transition of PNIPAAm has been studied extensively.  Lin et al. 
confirmed the existence of the balance between hydrophilic and hydrophobic forces with 
a study of PNIPAAm’s LCST using ATR/FTIR [161].  Below the LCST, they found that 
intermolecular hydrogen bonding between PNIPAAm and water accounted for 50-70% of 
the total molecular interactions by observing the amide I band on the spectra.  Above the 
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LCST, absorbance of the amide II band indicated that 70% of the molecular interactions 
were due to intramolecular hydrophobic interactions between PNIPAAm molecules.  
Maeda et al. found similar changes in the amide I and amide II bands in their study of 
copolymers of NIPAAm with acrylamide (AAm) and acrylonitrile (AN) [162].    With 
the PNIPAAm/PAN copolymer they observed hydrogen bonding interactions on 100% of 
the C≡N groups on AN below the LCST.  However when the temperature of the 
copolymer was raised above the LCST, it was observed that 90% of the C≡N groups 
became dehydrated [162]. 
 Winnik used fluorescence techniques on pyrene-labeled PNIPAAm and found 
changes in pyrene monomer emission when the temperature of an aqueous PNIPAAm 
solution was raised from below the LCST to above the LCST [163].  He interpreted these 
changes to be a shift from hydrogen bonding to hydrophobic interactions when the 
temperature was raised above the LCST.  The specific morphological configurations of 
the PNIPAAm polymer chains above and below the LCST were studied by Wang et al. 
with light scattering experiments [164].  By monitoring the radius of gyration (Rg) of the 
polymer chains in dilute solution, they observed the coil to globule collapse of the chains 
upon heating above the LCST and globule to coil transition upon cooling back to below 
the LCST.  A hysteresis was observed indicating that the globule to coil transition does 
not occur reversibly.  Wang et al. attributed this hysteresis to changes in interactions with 
PNIPAAm chains in the globule state, specifically intrachain hydrogen bonding [164].    
2.6.2 PNIPAAm Copolymers 
 To change the LCST of PNIPAAm, researchers have altered the balance of 
hydrophilic/hydrophobic forces by copolymerizing PNIPAAm with both hydrophilic and 
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hydrophobic components.  Hydrophilic components will naturally raise the LCST of a 
PNIPAAm copolymer, while hydrophobic components lower the LCST. 
 To create micelles that have temperature sensitive characteristics, researchers 
have created di-block copolymers of PNIPAAm and poly(butylmethacrylate) [165], 
cholic acid [166], and poly(acrylic acid) [167].  Hasan et al. have created tri-block 
copolymers of PNIPAAm-PPO-PNIPAAm which exhibit two distinct LCST transitions:  
one from the PNIPAAm and one from the polypropylene glycol, which like PNIPAAm 
also has thermosensitive properties [168].   
 Zhang et al. [169] and Kim et al. [170, 171] have processed interpenetrating 
polymer networks (IPNs) of PNIPAAm and PVA to increase the hydrophilicity of 
PNIPAAm above the LCST temperature.  Additionally, PNIPAAm has been grafted onto 
many hydrogel systems including hydrogelatin [172], alginate [173], chitosan [174], 
crosslinked PVA [175-177], and poly(acrylic acid) (PAA) [178]. 
 Some researchers have created hydrogels that exhibit both temperature and pH 
sensitivity.  Kuckling has processed and investigated colloids formed from PNIPAAm 
polymers grafted with poly(2-vinylpyridine) (P2VP) [179-181].  pH swelling sensitivity 
has also been observed with thermosensitive interpenetrating polymer networks (IPNs) of 
PNIPAAm and poly(methacrylic acid) (PMAA) [182], as well as copolymers of 
PNIPAAm and PMAA [183].   
 Oh et al. have designed hydrogel particles from PNIPAAm networks that are 
crosslinked with hexachlorocyclophosphazene trimers making them degradable [184].  
Neradovic et al. have created copolymers from NIPAAm and 2-hydroxyethyl 
methacrylate-monolactate (HEMA-monolactate) [185, 186].  When swollen in aqueous 
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solution, the lactate side groups are cleaved by hydrolysis leaving a poly(NIPAAm-co-
HEMA) hydrogel that has a higher hydrophilicity and thus a higher LCST.    
2.6.3 Biomedical Uses for PNIPAAm 
 Much of the research involving PNIPAAm has been motivated by the prospect of 
releasing therapeutic proteins from crosslinked hydrogel PNIPAAm networks.  These 
traditionally crosslinked networks are different than linear PNIPAAm in they are not 
soluble in aqueous solutions below the LCST.  With hydrogel networks, drastic changes 
are observed in swelling at the LCST instead of changes in polymer miscibility.  
Discontinuous volume changes in PNIPAAm hydrogel networks have led them to be 
investigated as materials that can be used for on-off switches for controlled drug delivery.  
Hoffman conducted some of the earliest PNIPAAm release experiments with loading and 
releasing Vitamin B12 and myoglobin from hydrogels made from PNIPAAm and a 
copolymer of PNIPAAm and poly(methacrylic acid) (PMAAc) [187-189].  With the 
release of Vitamin B12 from a PNIPAAm network, Hoffman observed first order release 
that resembled normal Fickian diffusion.  Above the LCST, a initial rapid release or burst 
effect was observed when the polymer network collapsed [189]. 
 Park investigated a release of insulin from a hydrogel formed from the 
copolymerization of NIPAAm with N,N’-dimethylaminopropylmethacrylamide 
(DMAPMAAm) [190].  These networks exhibited both temperature and pH-sensitivity in 
swelling.  However Park found that insulin release was not pH-responsive the way 
swelling was.   Wu et al. conducted release experiments of BSA and insulin from 
PNIPAAm hydrogels [191].  They observed 3.4°C increases in the LCSTs of the 
networks with incorporation of BSA and insulin and hypothesized that strong interactions 
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between BSA and PNIPAAm prevented complete protein release.  Insulin was 
completely released from the PNIPAAm network after 48 hours in vitro.  The ability to 
deliver vascular endothelial growth factor from PNIPAAm copolymer network has also 
been shown [192].  
 Instead of releasing therapeutic agents from a PNIPAAm network, some use the 
LCST as a means for recovery of specific proteins.   Ding et al. conjugated trypsin to 
PNIPAAm oligomers and then recovered the enzyme by heating the trypsin-PNIPAAm 
conjugate above the LCST [193].   
 Okano et al. have grafted PNIPAAm and PNIPAAm copolymers on material 
surfaces and showed cell attachment/detachment to be temperature sensitive [194-197].  
PNIPAAm grafting on culture surfaces eliminates the need for serum or trypsin to 
remove sheets of cells.  Lowering the temperature of the surface below the LCST of the 
system turns the surface from a hydrophobic cell adhering surface to a hydrophilic 
surface that cells detach from.    This enzyme-free recovery of cells with this thermal 
system reduces damage done to cells during harvesting.  Using PNIPAAm copolymers 
with n-butyl methacrylate (BMA), Tsuda et al. showed that they could vary the LCST of 
the system and effectively control bovine endothelial cell attachment/detachment at a 
variety of temperatures [197].  Poly(N-isopropylacrylamide-co-2-
carboxyisopropylacrylamide) P(IPAAm-co-CIPAAm) copolymer surfaces were modified 
with RGDS peptides by Ebara et al. [195].  They showed that binding of cell integrins to 
immobilized RGDS sequences on the culture surface could be interrupted by lowering the 
temperature below the LCST of the copolymer.  At temperatures below the LCST, the 
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polymer chains extended and swelled, shielding the access of the immobilized sequences 
from cell integrins [195]. 
 Chen et al. grafted poly(N-isopropylacrylamide-co-acrylic acid) / azidoaniline 
onto patterned surfaces and showed that selective fibroblast detachment could be 
achieved by lowering the surface temperature below the LCST [198].  Cell patterns were 
created by Yamato et al. using localized laser ablation of PNIPAAm modified surfaces 
that were treated with fibronectin and seeded with hepatocytes [196].   
 Healy’s research has focused on investigating PNIPAAm copolymers for the 
application of injectable tissue engineering scaffolds [199-204].  Stile et al. demonstrated 
that hydrogels made from poly(NIPAAm-co-AAc) had less volume change, higher water 
content, and a higher LCST than hydrogels made from pure PNIPAAm [201].  Bovine 
articular chondrocyte viability was supported by the hydrogels and the formation of 
cartilage-like tissue in vitro was observed [201].  They functionalized the P(NIPAAm-co-
AAc) copolymer with peptide sequences of –RGD- and –FHRRIKA- and found that rat 
calvarial osteoblasts demonstrated greater proliferation when seeded on the peptide-
modified hydrogels than the control copolymer hydrogels [200].  Stile and Healy have 
also investigated semi-interpenetrating networks (semi-IPNs) of poly(NIPAAm-co-AAc) 
with linear poly(AAc) [202] for evaluation of their ability to support expansion of cell 
types in a mouse heart model [203].  In a tissue engineering application, the degradation 
of these loosely crosslinked PNIPAAm copolymer matrices has been proposed to occur 
via enzymatic degradation with the incorporation of an oligopeptide crosslinker.  Kim 
and Healy have shown that the rate of hydrogel degradation to be dependent on the 
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crosslink density and the concentration of collagenase enzymes involved in cell migration 
[204].   
2.6.4 Swelling and De-swelling Kinetics 
 Okano et al. showed that above the LCST, the initial deswelling or shrinkage 
occurs on the hydrogel surface [205].  Other researchers have observed a dehydrated 
layer having a denser structure than the bulk hydrogel serves as a diffusion barrier for 
water and solutes entering or leaving the bulk of the hydrogel [206-208].  After this layer 
forms, the bulk of the hydrogel continues to transition from a solution to two phases 
(polymer and water).  This phase separation occurs and free water accumulates within the 
hydrogel.  The shrinkage of the hydrogel in this outer layer has been shown to actually 
result in the building of an internal hydrostatic pressure within the hydrogel [209].  In 
turn, the internal pressure causes entrapped water to flow out of the hydrogel in the form 
of large bubbles on the hydrogel surface.  The formation of an outer layer and outflow of 
water bubbles in PNIPAAm hydrogels, which have been studied by Dhara et al. [210] 
and Kanko et al. [209], limits the applications of these hydrogels, especially in controlled 
drug delivery.   
 Zhang and Zhuo have shown that the surface properties of PNIPAAm hydrogels 
can be greatly improved by carrying out polymerization in gelated corn starch aqueous 
solution [211].  They theorized that the formation of hydrogen bonds between hydroxyl 
groups on corn starch and amide groups on PNIPAAm chains prevented a dehydrated 
surface layer formation by allowing water to controllably enter and leave the hydrogel 
[211].           
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 Much research has been devoted to increasing the rate with which the LCST 
transition takes place.  This is often done by creating macropores through which water 
can channel out of the network when the temperature is raised above the LCST.  
Enhancement of the swelling and deswelling rates of  PNIPAAm based hydrogels has 
been achieved by redox polymerization in the presence of mixed solvents, such as 
water/acetone [212, 213] and water/1,4-dioxane [214].  To increase the response rates of 
PNIPAAm hydrogels through water release channels, Zhang et al. created semi-
interpenetrating polymeric networks (semi-IPNs) of PNIPAAm and polyamidoamine 
PAMAM dendrimers [215].  PNIPAAm polymerizations at cold temperatures (-18 to -
22°C) [212, 216, 217] and cold treatments of equilibrium swelled PNIPAAm hydrogels 
at below freezing temperatures (-11 to -40°C) [206, 218] were also shown to speed up the 
deswelling rate of PNIPAAm hydrogels. 
 Others have enhanced the response rate of PNIPAAm hydrogels by polymerizing 
in the presence of NaCl [219], silica particles [220, 221], sucrose solutions [222], or 
polyethylene glycol (PEG) [223, 224] to create more heterogeneous porous structures.  
Researchers who have used PEG as a pore forming agent have demonstrated that they can 
control the response rate of the hydrogel by varying the concentration and MW of PEG 
[223, 224].   
2.6.5 Systems using PNIPAAm and PEG 
 In addition to using PEG as a pore forming agent, some researchers have created a 
variety of systems composed of PNIPAAm and PEG.  Kim et al. have created 
PNIPAAm/PEO semi Interpenetrating Polymer Networks (sIPN) [225].  They found 
increases in swelling as the PEO content was increased, which is expected.  However, 
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they observed unexpected decreases in the LCST with increasing PEO concentration, 
which they did not explain.  Additionally, the LCST onsets of the DSC plots they present 
are within the range of 36.8-38.2°C which seems too close to the temperature of the 
physiological environment [225].   
 Kaneko et al. have grafted PEG chains onto networks of crosslinked PNIPAAm to 
increase the equilibrium swelling of traditionally crosslinked PNIPAAm hydrogels and 
the deswelling rates of the hydrogels when the temperature was raised above the LCST 
[226-228].  Chen et al. grafted PEO chains (MW=5,000) onto PNIPAAm chains [229].  
Due to their polymerization conditions, they were able to form nanostructures above the 
LCST with a collapsed PNIPAAm core and a swollen PEO shell.  However, their studies 
deal only with very dilute polymer solutions.   Kono grafted PEG grafts (MW=550) onto 
NIPAAm and N-acryloylpyrrolidine copolymer modified liposomes [230] and found the 
PEG grafts increased the temperature sensitive release from the liposomes.  Bhalerao et 
al. used γ-irradiation crosslinking to form PEO hydrogels with PNIPAAm grafts that 
exhibit an LCST [231].   
 Topp et al. have demonstrated the temperature sensitivity of micelles formed from 
PNIPAAm-PEG di-block copolymers [232].  They proposed a burst release of drug from 
these micelles with hypothermia.  Using atom transfer radical polymerization, Kim et al. 
showed they could also use PNIPAAm-PEG di-block copolymers to form temperature 
sensitive hydrogel nanoparticles with enhanced kinetics [233].  Neradovic has 
extensively researched degradable di-block copolymers of poly(NIPAAm-co-N-(2-
hydroxypropyl) methacrylamide-dilactate) (poly(NIPAAm-co-HPMAm-dilactate)) that 
form micelles above the LCST and have the potential to deliver therapeutic agents [234-
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236].   The degradation of these micelles is via hydrolysis of the HPMAm-dilactate 
segments [234-236].    
 Ma et al. have created PNIPAAm hydrogels that are branched with PEG chains of 
varying lengths [237].  They varied the length of the PEG branches from 1 unit (MW=44 
g/mol) to 23 units (MW≈1000 g/mol) and the concentration of PEG from 2-7.5 molar % 
[237].  Increases in PEG branch length led to microhydrogels with higher hydrodynamic 
diameters.  They also observed with 1H-NMR studies that raising the temperature of the 
polymer system above the LCST caused the concentration of PEG protons on the surface 
of the system to increase indicating above the LCST, PEG chains remained hydrated and 
gathered at the surface while the PNIPAAm network had collapsed [237]. 
2.6.6 Mechanics 
 Researchers have tested the mechanical properties of PNIPAAm-based hydrogels 
with a number of different methods.  For many of the reported studies, mechanical 
properties were evaluated to determine the effects of processing conditions on the 
hydrogels.  With exception of Kim and Healy’s studies, researchers have not investigated 
PNIPAAm based hydrogels as potential replacements for load bearing tissues within the 
body. 
 With tensile tests, Takigawa et al. determined the Young’s modulus of 
crosslinked PNIPAAm hydrogels to be between 150-170 kPa [204, 238, 239].  In their 
studies, they have also calculated a Poisson’s ratio of PNIPAAm as 0.43 [238].  They 
conducted tensile stress relaxation studies on PNIPAAm hydrogels and broke down 
relaxation into three components or mechanisms:  elastomeric relaxation, relaxation due 
to breakdown of physical crosslinks, and swelling-induced relaxation [238].   The tensile 
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studies by Liu and Sheardown were limited because only mechanical properties of their 
polymers in the dry state were presented [240].  
 Others have used Atomic Force Microscopy (AFM) experiments to study local 
elastic properties of PNIPAAm-based hydrogel films [241-244].  The Young’s Modulus 
of a film can be calculated from the AFM force-deflection (F-δ) plots with the Hertz 
model [245].  With a conically shaped tip, the model predicts Equation 2.1: 
2
21
tan2 δυπ
α
−=
EF          Equation 2.1 
 
where F is loading force, α is open angle of the tip, δ is indentation depth, E is elastic 
modulus, and υ is Poisson’s ratio of the surface material.  For all of the AFM studies 
cited, υ was assumed to be 0.5.   
 Reported compression modulus values of PNIPAAm based hydrogels range from 
0.7-600 kPa.  This range is relatively small when considering the variety of different 
copolymers, processing techniques, crosslink densities, and polymer concentrations used.  
A common trend among this collection of reported values is a stiffening of the hydrogel 
network with increases in crosslink density or decrease in water content.  Zhang et al. has 
reported values of compression modulus for different PNIPAAm systems between 5.4-34 
kPa [246-248].  Perhaps the only criticism of these studies is that the tests were 
conducted at 22°C instead of physiological temperature.  While this is a minor feature for 
mechanical tests of most biomaterials, PNIPAAm based hydrogels exhibit drastically 
different swelling and mechanical properties below and above the LCST.  Rathjen et al. 
reported ultimate compressive stresses and strains for crosslinked PNIPAAm processed at 
different temperatures, however they failed to report calculated stiffness values [249].  
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The relatively high compressive modulus values reported by Serizawa et al. (120-160 
kPa) are likely elevated due to the test method that was employed [220].  Compression 
tests on discs less than 1mm in thickness likely resulted in flattening of the sample which 
can result in load measurement of the stiffness of the plate opposite the load cell instead 
of the hydrogel film itself.  Shin et al. [250] and Lee and Yeh [251] have performed 
compression tests on PNIPAAm in conjunction with equilibrium swelling studies to 
determined apparent effective crosslink densities.  Ho et al. designed injectable 
PNIPAAm/PEG hydrogels crosslinked with 3-(methacryloxy)propyltrimethoxysilane 
(MPS) that had compressive modulus values above 0.6 MPa [252]. 
 Kim and Healy have performed dynamic shear oscillation experiments on peptide 
crosslinked P(NIPAAm-co-AAc) hydrogels and found the complex modulus to increase 
from 55-110 Pa between 0.001-10 Hz [204].  Zhang et al. studies using a dynamic 
mechanical analyzer (DMA) showed that mechanical strength of their PNIPAAm IPNs 
was higher than that of traditionally crosslinked PNIPAAm hydrogels [253].  
 A summary of these studies is found in Table 2.1. 
2.7 Other Thermogelling Systems 
 In addition to PNIPAAm and its copolymers, there are other systems that exhibit 
LCST behavior in aqueous solution and could potentially be used as injectable 
biomaterials.  Harsh and Gehrke have created crosslinked cellulose ethers that exhibit 
sharp LCSTs [254].  Inoue et al. and Lozinsky et al. have reported on crosslinked poly(N-
vinylcaprolactam) polymers that exhibit LCSTs between 28-40°C [255, 256].  Lee et al. 
processed multiblock copolymers of poly(ε-caprolactone) (PCL) and PEG that have 
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LCSTs and form hydrogels with associating PCL block segments at physiological 
temperature [257].     
 Jeong et al. have investigated PEG-g-PLGA and PLGA-g-PEG copolymers that 
are low viscous solutions at room temperature and become hydrogels at 37°C [258, 259].  
They have shown in a New Zealand White rabbit knee model that PLGA-g-PEG polymer 
solutions can be injected with autologous chondrocyte cells to fill and repair cartilage 
defects [258].  Bhattarai et al. have shown that chitosan-g-PEG systems can be injected as 
aqueous solutions at room temperature, form hydrogels at 37°C, and release a model 
protein, bovine serum albumin (BSA) [260, 261].   
  Various tri-block copolymers that exhibit LCST behavior have been formed.  
Perhaps the most famous of theses  block copolymer systems are the poloxamers (PEO-
PPO-PEO) [262].  Jeong et al. have investigated degradable PEG-PLGA-PEG and PEG-
PLLA-PEG polymers for drug delivery systems [263-266].  The LCST behavior has also 
been observed for tri-block copolymers composed of dendritic citric acid (CA) and PEG 
in a CA-PEG-CA structure [267].       
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Table 2.1 Literature review of mechanical properties of PNIPAAm-based 
hydrogels 
Author Material Test Results Comments 
Takigawa et al. 
[239] 
Crosslinked 
PNIPAAm 
Tensile test @ 
40°C 
Young’s Modulus: 
PNIPAAm (170 
KPa) 
Strain at break : 
(0.35) 
Increase in Temp. 
to 65°C did not 
change Young’s 
Modulus 
significantly  
Takigawa et al. 
[238] 
Crosslinked 
PNIPAAm 
Tensile stress 
relaxation @ 40°C 
Young’s Modulus: 
(150 kPa) 
Poisson’s ratio: 
(0.43) 
Stress relaxation 
controlled by 
swelling under 
tension 
Liu and 
Sheardown [240] 
IPN of PNIPAAm 
and PDMS Tensile test 
Young’s Modulus: 
(0.2-9 MPa) 
Only data 
presented was for 
dry polymers 
Matzelle et al. 
[243] 
Crosslinked 
PNIPAAm 
hydrogels 
AFM experiments 
in water @ 40°C 
Young’s Modulus: 
(13.9-117 kPa) 
Increase in 
Young’s Modulus 
with crosslink 
density 
Ohya et al. [244] Hydrogelatin with PNIPAAm grafts 
AFM experiments 
in water @ 37°C 
Young’s Modulus: 
(52-244 kPa) 
Young’s Modulus 
dependent on graft 
density 
Harmon et al. 
[241, 242] 
PNIPAAm with 
DMAAAm 
crosslinker 
AFM experiments 
in water @ 42°C 
Young’s Modulus: 
(486-1540 kPa) 
Young’s Modulus 
dependent on 
crosslink density 
Ohya and Matsuda 
[172] 
Hydrogelatin with 
PNIPAAm grafts 
Unconfined 
compression @ 
22°C 
Compression 
Modulus: (0.7-8.7 
kPa) 
Modulus 
dependent on graft 
density and 
polymer 
concentration 
Zhang et al. [246] 
Crosslinked 
PNIPAAm with 
PCL based 
microspheres 
Unconfined 
compression @ 
22°C 
Compression 
Modulus: (11.6-
12.5 kPa) 
Modulus 
decreased slightly 
with increase in 
microsphere 
concentration 
Zhang and Chu 
[248] 
Crosslinked 
PNIPAAm with 
PNIPAAm/PEG 
microhydrogels 
Unconfined 
compression @ 
22°C 
Compression 
Modulus: (12.7-34 
kPa) 
N=2 for each 
sample 
Zhang et al. [247] 
PNIPAAm / 
Dextran-Al 
copolymers 
Unconfined 
compression @ 
22°C 
Compression 
Modulus: (5.4-
27.7 kPa) 
Modulus 
increased with 
increase in 
Dextran-Al 
concentration  
Lee and Yeh [251] 
Crosslinked 
PNIPAAm 
copolymers (with 
OFPMA and 
BMA) 
Unconfined 
compression @ 
25°C 
Compression 
Modulus: (33-115 
kPa) 
Modulus used to 
calculated 
apparent crosslink 
density 
Serizawa et al. 
[220] 
Crosslinked 
PNIPAAm and 
macroporous 
PNIPAAm 
Unconfined 
compression @ 
25°C   
Compression 
Modulus: (120-
160 kPa) 
Aspect ratio of 
discs too small 
(t<1mm) which 
explains high 
modulus values  
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Shin et al. [250] 
IPNs of 
PNIPAAm and 
PAA 
Unconfined 
compression on 
rectangular 
samples @ 44°C 
Compression 
Modulus: @ pH=3 
(125 kPa), @ 
pH=4.6 (19.5 kPa) 
Aggregate stress 
values recorded 
instead of 
instantaneous.  
Modulus used to 
calculated 
apparent crosslink 
density 
Ho et al. [252] 
PNIPAAm/PEG 
crosslinked with 
MPS 
Unconfined 
compression @ 
37°C 
Compression 
Modulus: above  
0.6 MPa 
After 5 days 
immersion in SBF 
solution 
Rathjen et al. 
[249] 
Crosslinked 
PNIPAAm 
Unconfined 
compression @ 
22°C 
Ultimate Stress: 
(0.74-2.55 kPa) 
Ultimate Strain: 
(0.51-0.63) 
Ultimate Stress 
and Strain 
decreased with 
increasing 
polymerization 
temperature 
Kim and Healy 
[204] 
Peptide and 
traditionally 
crosslinked 
P(NIPAAm-co-
AAc) hydrogels  
Parallel plate 
rheometer @ 37°C 
Complex Modulus 
(G*) increased 
from 55-110 Pa 
between 0.001-10 
Hz 
Peptide and 
traditionally 
crosslinked 
hydrogels showed 
same rheological 
data 
Zhang et al. [253] 
Crosslinked 
PNIPAAm and 
PNIPAAm IPN 
DMA (parallel 
plate) @ 25°C 
Static modulus: 
PNIPAAm (20-
160kPa), IPN (20-
290kPa) 
IPN had higher 
crosslink density 
and higher 
polymer volume 
fraction than 
PNIPAAm 
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Figure 2.1   SB Charité Intervertebral Disc [268] 
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Figure 2.2   ProDisc-L Intervertebral Disc [269] 
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Figure 2.3   Maverick Intervertebral Disc [269] 
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Figure 2.4   Flexicore Intervertebral Disc [269] 
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Figure 2.5   Acroflex-100 Intervertebral Disc [270] 
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Figure 2.6 Newcleus Nucleus Replacement [31] 
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Figure 2.7 Prosthetic Disc Nucleus (PDN) [73] 
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polymer and 
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Tem
perature
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                                     (a)        (b) 
 
Figure 2.8 Comparison of the phase diagrams for polymers having an (a) upper 
critical solution temperatures (UCST) and (b) lower critical solution 
temperature (LCST) 
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Figure 2.9 Chemical structure of Poly(N-isopropylacrylamide) 
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3 Research Goals 
The long range goal of this project is to design an injectable material to serve as a 
nucleus pulposus replacement for the treatment of intervertebral disc degeneration.  Our 
approach for making an injectable nucleus implant is to use polymers that exhibit Lower 
Critical Solution Temperatures (LCST) between room and body temperatures.  Solutions 
of polymers exhibiting LCSTs can be injected into the nuclear cavity as a viscous fluid at 
25°C and warm to form a hydrogel at 37°C.  Poly(N-isopropylacrylamide) (PNIPAAm), 
a polymer extensively studied for pharmaceutical applications, has an LCST between 32-
34°C making it a candidate material for an injectable orthopedic biomaterial.  At body 
temperature however, PNIPAAm displays hydrophobic characteristics and has virtually 
no elastic response. 
Hypothesis:  Using polymers that exhibit LCSTs, we can create a hydrogel system that 
can be injected as a viscous liquid at 25°C and solidify to a hydrogel within the body.  
Covalent incorporation of PEG into a PNIPAAm polymer structure with either PEG 
grafts or branches can produce physically and chemically stable hydrogels with suitable 
swelling ratios and mechanical properties for a load bearing orthopedic application.  
 The specific aims of this thesis are: 
1. Process and characterize PNIPAAm polymers with both PEG branches 
and PEG grafts that have LCST in aqueous solution between ambient and 
body temperature. 
2. Evaluate the swelling properties of the family of polymers with immersion 
in biologically relevant media. 
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3. Evaluate the effect that the osmotic environment of the intervertebral disc 
will have on the swelling properties of the precipitated hydrogel. 
4. Investigate the effect of changes in polymer concentration on phase 
transition behavior for hydrogels made from PNIPAAm and two 
candidates from the family of copolymers. 
5. Evaluate the effects that compressive loading cycles have on the properties 
of hydrogels made from PNIPAAm and two candidates from the family of 
copolymers. 
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4 Polymer Processing and Characterization 
4.1 Introduction 
 This chapter details polymerization technique and purification methods.  The 
polymer stoichiometries were confirmed using proton Nuclear Magnetic Resonance (1H-
NMR).  Relative molecular weights of the polymers were estimated using the Mark-
Houwink-Sakurada equation linking the intrinsic viscosity of a polymer solution with the 
molecular weight of the polymer.  Thermal analysis was conducted on 25% polymer 
solutions using differential scanning calorimetry (DSC).  In addition, DSC experiments 
were conducted on different polymer concentrations to study the effect on LCST. 
4.2 Experimental 
4.2.1 Polymer Synthesis 
N-Isopropylacrylamide, 97% (NIPAAm, Aldrich, Mw=113.16 g/mol) was 
purified by dissolving in hexane, ≥98.5% (Sigma-Aldrich) in roughly a 1g NIPAAm / 3 
mL hexane ratio at 55°C followed by precipitation at 25°C.    The mixture of hexane with 
NIPAAm precipitate was vacuum filtered to isolate the purified NIPAAm, and then dried 
in a vacuum oven at 25°C for 24 hours.   
Purified NIPAAm was copolymerized with poly(ethylene glycol) 1000 
monomethyl ether monomethacrylate (PEGM 1000, Polysciences, Mw=1100.66 g/mol) 
and poly(ethylene glycol) 1000 dimethacrylate (PEGDM 1000, Polysciences, 
Mw=1154.09 g/mol) to form PNIPAAm with PEG grafts and PNIPAAm with PEG 
branches, respectively (Figure 4.1 and Figure 4.2).  The reaction components were mixed 
in sealable glass jars with methanol, ≥99.9% (Sigma-Aldrich) as a solvent.  The 
polymerizations were initiated with 2,2’-Azobisisobutyronitrile, 98% (AIBN, Aldrich).  
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Each reaction mixture was purged with dry N2 for 5 minutes before being sealed with a 
cap.  The polymerizations were conducted at 65°C for 48 hours in a Precision reciprocal 
shaker bath, after which the reaction mixtures were dried to remove methanol.  After 
further removal of methanol by drying in a vacuum oven, the polymers were ground in a 
Braun coffee grinder and purified by filtration in 55°C hexane to remove any residual 
unreacted monomer.   
A family of copolymers was created by modifying three variables in the 
polymerization reaction: 
• PEG functionality (mono- or di-functional) 
• Composition ([NIPAAm]/[PEG]) 
• Monomer / initiator ratio (([NIPAAM]+[PEG]) / [AIBN]) 
Two matrices, depicted in Table 4.1, were formed from varying these controls.    In these 
matrices, the ratio of [NIPAAm]/[PEG] is on a molecular basis such that a 300/1 
NIPAAM/PEG hydrogel was prepared with a ratio of 300 NIPAAm repeat units / 1 
functionalized PEG chain.  The molecular weights of PEGM 1000 and PEGDM 1000 are 
based on reported averages of the PEG portion of the chains (1000) added to the 
molecular weight of the end groups.  Both PEGM 1000 and PEGDM 1000 chains contain 
on average 22.7 individually linked PEG repeat units – each contributing 44 g/mol.  
Another way to designate the chemistry of these polymers is on a repeat unit to repeat 
unit basis, where the number of NIPAAm repeat units is compared to the number of 
individual PEG repeat units.  By comparing repeat units of NIPAAm to repeat units of 
PEG, a molar % of PEG can be calculated.  Table 4.2 has two matrices that were formed 
using this designation standard.   
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4.2.2 Extent of Reaction 
 The extent of polymerization for NIPAAm with monofunctional PEGM 1000 was 
evaluated with a Nicolet 560 Attenuated Total Reflectance – Fourier Transform Infrared 
Spectroscopy (ATR-FTIR) (Madison, WI).  This initial study was conducted early on in 
the project to determine the appropriate reaction time needed for the polymerizations.  
The reaction components were mixed as described in section 4.2.1 with a 
[NIPAAm]/[PEGM 1000] ratio of 2000/1 (molar % PEG=1.1%) and a 
([NIPAAm]+[PEGM 1000])/[AIBN] ratio of  200/1 into 7 vials.  After 0, 1, 2, 4, 8, 24, 
and 48 hours of reaction at 65°C, vials were removed from the shaker bath and quenched 
in ice water.  The 0 hour time point reflected a vial in which the reaction components 
were mixed but not heated in the shaker bath.  Upon quenching of each vial, the reaction 
mixtures were pipetted onto the ZnSe ATR-FTIR crystal and scanned for 1024 scans at a 
4cm-1 resolution.  Backgrounds of pure methanol were used for the tests of each reaction 
mixture.     
4.2.3 Chemical Analysis 
 Solution state proton Nuclear Magnetic Resonance (1H-NMR) was used to 
confirm the polymer chemistry (specifically NIPAAm/PEG ratios) that was intended for 
each polymer sample.  After purification, 10 mg of each polymer was dissolved in 1 mL 
of Deuterium oxide, 99.9 atom% D (D2O, Aldrich, MW=20.03 g/mol) overnight.  The 
resulting polymer solutions were pipetted into 5 mm x 7 in NMR tubes (Sigma-Aldrich) 
and sealed with caps.  The samples were tested (n=2) with a Varian 300 NMR (Palo Alto, 
CA).  Spectra, obtained with 100 scans of each sample, were analyzed with VNMR 
software (version 6.1B).   
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4.2.4 Capillary Viscometry 
 The intrinsic viscosities of the polymers were determined using capillary 
viscometry.  Tests were conducted using an Ubbelohde type capillary viscometer 
immersed in a water bath that was controlled at 20°C.  The polymers were tested with 
either a size 50 or size 100 Cannon Instrument Company viscometer.  An aqueous 
solution was prepared for each polymer.  Efflux time measurements were recorded using 
a timing device that could be read to 0.01 seconds.  Relative viscosities were determined 
by taking the average efflux time (at least n=3) for three or more concentrations.   
4.2.5 Thermal Analysis 
 Twenty-five percent aqueous solutions were made of each purified polymer by 
mixing the ground polymer powder with DI water in 50 mL polypropylene conical tubes.  
To achieve homogenous solutions, the mixtures were agitated with a vortex mixer.  For 
the branched polymer samples rich in PEG (molar % PEG ≥ 7%), physical mixing with a 
spatula aided in the creation of homogenous solutions.  After mixing the polymers into 
solution, the solutions were centrifuged (Sorvall Legend Mach 1.6R) at 9,230 RPM 
(RCF=12,000g) at 20°C for 45 minutes to remove entrapped air bubbles.    
 The thermal transitions of these solutions were studied with a differential 
scanning calorimeter (DSC) (DSC 2010, TA Instruments, Newark, DE) calibrated for 
temperature and heat flow with an indium standard.  A small portion of each polymer 
solution (generally between 10.0mg and 14.0mg) was measured and encapsulated within 
an allodized Aluminum pan and lid, and hermetically sealed with a standard die press.  
The tests were run by heating the polymer from 15°C to 50°C at 5°C/min (n=3 for each 
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polymer).  The LCST and enthalpy change with the LCST transition were determined for 
each DSC scan with TA Instruments Universal Analysis software (version 2.5H).   
 In addition, polymers made with pure PNIPAAm, PNIPAAm with 7% PEG 
grafts, and PNIPAAm with 7% PEG branches were dissolved in aqueous solutions with 
polymers concentrations of  1, 3, 5, 10, 15, 20, 25, and 30% in the same manner 
described above (n=3 for each concentration).  LCST values were determined as 
described above.   
4.2.6 Statistical Analysis 
 For comparison of data sets, Minitab Statistical Analysis Software (Version 
13.30) was used to conducted one-way analysis of variance (ANOVA) tests.  To 
determine statistical significance, a 95% confidence interval (p<0.05) was used.  The p 
value was reported to describe to characterize significance when the confidence interval 
was greater than 95%.   
4.3 Results 
4.3.1 Polymer Synthesis 
 With polymerization, the reaction mixtures in methanol became more viscous.  
For the more heavily branched polymers (molar % PEG ≥ 7%), polymerization caused 
the reaction mixtures to become gel-like.  Polymerization with 31 molar% PEG branches 
resulted in a polymer hydrogel that lacked cohesiveness.  In methanol solution, this 
polymer hydrogel easily crumbled.  ATR-FTIR experiments were conducted before and 
after the purification step of filtration in 55°C hexane to confirm that the method was 
successful in removing residual unreacted monomer.   
  65
4.3.2 Extent of Reaction 
 A test reaction of PNIPAAm with PEG grafts was conducted to show that 48 
hours was sufficient time for completion of the reaction.  The ATR-FTIR spectra changed 
as the reaction progressed from a mixture of NIPAAm monomer, monofunctionalized 
PEGM 1000, AIBN (initiator), and methanol (solvent) to a grafted PNIPAAm polymer 
solution in methanol (Figure 4.3).  The peaks between 1000 cm-1 and 1037 cm-1 were 
obscured for the IR scans of solutions using a methanol background because methanol 
has a significant infrared absorbance in this range of wavelengths. 
 The changes in the spectra over reaction time confirm polymerization.  
Absorbance peaks at 808 cm-1, 917 cm-1, 966  cm-1, and 993 cm-1, due to out of plane C-
H bending vibrations within alkenes, were specifically strong with the mixture of 
reactants at 0 hours.  These peaks disappeared with the progression of the reaction due to 
the removal of monomer and to a much lesser extent functionalized PEG.   A significant 
band at 1622 cm-1, attributed to C=C stretching, also diminished as the reaction 
progressed.  Additionally, a minor absorbance band at 1410 cm-1, attributed to –CH=CH2, 
disappeared as the reaction progressed.  The band at 1245 cm-1, not identified to date, is a 
major absorbance for NIPAAm monomer, but was not present in tests conducted on 
PNIPAAm standards.  The 1245 cm-1 absorbance in NIPAAm monomer has also been 
observed by Kim et al. but not attributed to a specific stretch or bend vibration [225]. 
 The spectra after 48 hours of polymerization closely resembled spectra of 
PNIPAAm standard (both published spectra and spectra obtained in our labs).    Strong 
absorbances at 1650 cm-1 and 1554 cm-1, previously identified by various research groups 
[199, 225, 271] and attributed to C=O stretching (amide I) and N-H vibration (amide II), 
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were evident after 48 hours.  Lin et al. have used curve fitting techniques on the amide I 
and amide II absorbance peaks to dissect them each into 3 peaks assigned to C=O 
stretches and N-H vibrations that are free, hydrogen bonded intramolecularly, and 
hydrogen bonded intermolecularly [161].  The doublet peaks at 1387 cm-1 and 1369 cm-1, 
seen in Figure 4.3, are typically called the isopropyl split and are due to bending vibration 
within isopropyl groups in PNIPAAm.  In addition, the peak at 1172 cm-1 is also due to 
isopropyl groups in PNIPAAm.  The peak at 1460 cm-1, evident throughout the reaction, 
is  typical of antisymmetric deformation of CH3 groups found on PNIPAAm [271].   
4.3.3 Chemical Analysis 
 ATR-FTIR tests to quantify the ratio of NIPAAm / PEG in the polymers were 
unsuccessful due to the relatively small amount of PEG.  The absorbances for the 
concentration of PEG used were lower than the detection limit using IR-spectroscopy.  
1H-NMR spectroscopy was successful in confirming the concentrations of PEG present in 
each PNIPAAm polymer.  The areas of the peaks at δ≈0.99 ppm (labeled as a in Figure 
4.4) and δ≈3.6 ppm (labeled as b in Figure 4.4) were quantified using VNMR software.  
These peaks had been previously identified by Ma et al. [237]. For each test, the area of 
the peak around 0.99 ppm, proportional to number of methyl protons on isopropyl group 
on the PNIPAAm polymer, was compared to the area of the peak around 3.6 ppm, 
proportional to the number of protons on PEG 1000 chains.  These molar ratios, 
calculated with Equation 4.1, were compared to ratios that were used in the 
polymerization reactions, defined as [NIPAAm]/[PEG] (in Table 4.1).  The areas of the 
peaks a and b are divided by 6 and 86 protons respectively because these are the number 
of the hydrogens specifically responsible for the peaks on a PNIPAAm repeat unit and a 
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PEGM 1000 or PEGDM 1000 chain.  The tests were repeated for each polymer to 
confirm the calculated ratios.   
protons 86
(b) Area
protons 6
(a) Area
  ratiomolar  =       Equation 4.1 
Additionally, a molar% PEG was calculated for each polymer from the 1H-NMR data.   
 A summary of results of the spectral analysis is presented in Table 4.3.  The 
theoretical amounts of PEG in each polymer ([NIPAAm]/[PEG] and molar% PEG both 
listed) describe the expected amounts for the polymerizations.  Experimental data from 
1H-NMR is presented in both formats.  Calculations of PEG content matched well with 
the amounts prescribed in the polymerization reaction.  The concentrations determined 
for both PNIPAAm grafted and branched with PEG chains with a molar % PEG of 7.0 
deviated slightly when the [M]/[I] values were 20/1 and 600/1 instead of 200/1. 
4.3.4 Capillary Viscometry 
 Tests with an Ubbelohde capillary viscometer (pictured in Figure 4.5) using dilute 
polymer solutions were performed to calculate the intrinsic viscosities [η] of the 
polymers.  The Hagen-Poiseuille equation (Equation 4.2) describes the flow rate (Q) of 
solution through a capillary tube [272]:   
L8η
ΔpπRQ
4
=           Equation 4.2 
where R and L are the radius and length of the capillary, η is the viscosity of the solution, 
and Δp is the difference in dynamic pressure across the capillary (from gravity and static 
pressure effects).  Assuming that the densities of the polymer solution and solvent are 
similar, differences in Δp are negligible.  Therefore, for tests on the same capillary tube 
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having dimensions of R and L, flow rate is solely dependent on viscosity, which by the 
efflux time can be properly described.  The efflux time for a solution (t) can be divided 
by the efflux time for a pure solvent (to) to calculate the viscosity ratio of the solution (η) 
to the solvent (ηo) as shown in Equation 4.3 [157]: 
oo
rel η
η
t
t
η ==          Equation 4.3 
The ratio of η/ηo is also known as the relative viscosity (ηrel).  The non-linear 
relationship between relative viscosity and solution concentration, is described by a 
power series (Equation 4.4) [157]: 
[ ] ...kccη1
η
η
η 2
o
rel +++==         Equation 4.4 
where c is concentration of the polymer solution.  The intrinsic viscosity of the polymer, 
[η], and k are constants.  Because only dilute polymer solutions are used with the 
capillary viscometry method, terms of c3 and higher can be assumed to be negligibly 
small and disregarded.  With that assumption, rearrangement of Equation 4.4 gives 
Equation 4.5 [157]: 
[ ] kcη
η
ηη
c
1
c
η
c
1η
o
osprel +=⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=⎟⎟⎠
⎞
⎜⎜⎝
⎛=⎟⎠
⎞⎜⎝
⎛ −       Equation 4.5 
where specific viscosity (ηsp) is defined as ηrel-1.  The ratio of (ηsp/c) is often referred to 
as the reduced viscosity (ηred).  It can be easily seen from Equation 4.5 that as 
concentration becomes infinitely small (remember the use of dilute solutions), intrinsic 
viscosity can be represented by Equation 4.6 [157]: 
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Therefore if the reduced viscosity (ηred) is plotted versus concentration, a linear 
relationship should be observed with a y-intercept of the intrinsic viscosity ([η]).  
Deviations from linearity can occur with higher polymer concentration because of the 
assumption that concentration is small.     
 For these experiments, concentrations were chosen so that the values of ηrel were 
between 1.2 and 2.0.  A lower limit of 1.2 was chosen to ensure there would be precise 
measurable differences in efflux times between the solution and solvent.  Above ηrel 
values of 2.0, shear effects become more prevalent and the relationship in Equation 4.5 
becomes non-linear.  For the size 50 viscometer, which was used for tests on most of 
polymers, the average efflux time of pure DI water was 284.6 seconds.  Therefore 
acceptable efflux times for the Ubbelohde capillary tube varied between 341.5-569.2 
seconds.  The radius of the capillary in the size 50 viscometer proved too small for the 7 
molar % PEG branched polymers prepared with a [M]/[I]=200/1 and 600/1.  For these 
polymers, tests were conducted with a size 100 viscometer which had an average efflux 
time for DI water of 62.1 seconds.  Acceptable efflux times for the size 100 Ubbelohde 
capillary tube varied between 74.5-124.2 seconds.  The solution of polymer prepared 
with 31 molar % PEG branches was not tested as it was not homogenous. 
 Plots of reduced viscosity versus concentration for the polymers are found in 
Figure 4.6.  Linear trendline fits for the data were performed using Microsoft Excel.  
Extrapolations to concentration=0 were done to determine intrinsic viscosity values of the 
polymers.  In addition to the polymers processed in this study, tests of a PNIPAAm 
standard (reported Mn=20-25K) obtained from Sigma Aldrich were conducted (also 
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shown on Figure 4.6).  Figure 4.7 shows the data obtained for the 7 molar % PEG 
branched polymers prepared with a [M]/[I]=200/1 and 600/1 on the same graph with the 
other polymers tested.  These polymers, tested with the size 100 viscometer, showed 
significantly higher reduced viscosities than the other polymers at smaller concentrations 
(c < 0.0025 g/mL).  At higher concentrations, the relative viscosities of these polymers 
far exceeded the upper limit of 2.0.  The efflux times recorded for these two polymers 
were also more variable than the other 9 polymers tested.   
Values of intrinsic viscosity are found in Table 4.4.  Increases in [η] were 
observed with increasing PEG content (both PEG branches and PEG grafts).  The 
intrinsic viscosity for the Sigma Aldrich PNIPAAm standard was 39.7 mL/g which was 
very close the value obtained for the pure PNIPAAm polymer processed as a control for 
this study (39.1 mL/g).  For the polymers processed with 7% PEG grafts, intrinsic 
viscosity increased with increasing [M]/[I].  The increase in intrinsic viscosity was more 
dramatic for the additions of PEG branches than PEG grafts.  For example, increasing the 
PEG branch content from 2.2% to 3.6% caused a 16.4 mL/g increase in intrinsic viscosity 
while an increase in PEG graft content from the 0% (control) to 7% resulted in only a 0.3 
mL/g increase in intrinsic viscosity.  Intrinsic viscosity values were not reported for the 
two polymers tested with the size 100 viscometer because of inconsistent data.  Capillary 
viscosity experiments on these polymers are not valid as they form flowable hydrogels in 
water instead of solutions.   
Intrinsic viscosities are typically used to determine polymer molecular weights 
with use of the Mark-Houwink-Sakurada equation (Equation 4.7) [157]: 
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[ ] avMKη =           Equation 4.7 
where vM  is the viscosity average molecular weight and K and a are constants based on 
the polymer, solvent, and temperature of the solution being tested.  For pure PNIPAAm 
in aqueous solution at 20°C, Fujishige has determined the values of K and a to be 
14.5x10-2 and 0.50 respectfully [273].  These values are valid when the [η] is reported 
with the units of mL/g as was done in this study.  Researchers have used values of K and 
a from Fujishige’s experiments with monodisperse polymer fractions to determine 
molecular weights of PNIPAAm in aqueous solution [274, 275] and THF [276].   
For the polymers tested in this study, values of vM  calculated using the Mark-
Houwink-Sakurada constants reported by Fujishige are found in Table 4.5.  It is 
important to note that these are estimates using a semi-empirical formal and the K and a 
values determined by Fujishige were only for pure PNIPAAm and not PEG grafted or 
PEG branched PNIPAAm.  For comparative purposes, the Sigma Aldrich PNIPAAm 
standard reported as having a nM =20-25K was calculated to have a vM  of 75,000 g/mol 
by the viscometry method.   
4.3.5 Thermal Analysis 
 Figure 4.8 shows a representative DSC plot of a 25% solution of pure PNIPAAm 
polymer.  On the curve, the LCST onset and the LCST are marked.  Some researchers 
have defined the LCST as the onset of the endotherm of the transition on a DSC plot 
[225].  However, most have defined the LCST as the minimum of a plot of the 
endothermic transition (with exothermic heat as the positive y axis direction) [199, 274, 
277].  For these studies, the latter definition was used.   Calculations of endothermic peak 
area to determine the ΔH of the transition were conducted using sigmoidal horizontal 
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baselines.  A sigmoidal baseline is an S-shaped line that changes in level and/or slope 
before or after a peak.  It is often used to compensate for changes in a baseline that occur 
during a transition.   
 For polymers prepared with [M]/[I]=200/1, a plot of LCST versus % PEG is 
found in Figure 4.9.  As expected, PEG grafts and branches both increased the LCST of 
the pure PNIPAAm polymer.  PEG is hydrophilic and shifted the balance of the 
hydrophobic/hydrophilic LCST transition to higher temperatures.   The LCST of the 7% 
PEG grafted polymer was significantly higher than that of pure PNIPAAm (p<0.001) and 
7% PEG branched polymers (p<0.001).  For the polymers prepared with 31% PEG, 
branches resulted in a significantly higher LCST than grafts (p<0.05).  The 31% PEG 
polymers (both grafted and branched) had LCST values above 37°C (PEG branches) or 
too close to 37°C (PEG grafts) for the application.  When the [M]/[I] was increased from 
20/1 to 200/1, there were significant increases in LCST of almost 1°C for both polymers 
prepared with 7% PEG grafts (p<0.005) and 7% PEG branches (p<0.005) (Figure 4.10).  
However when the [M]/[I] for those two polymers was raised from 200/1 to 600/1 there 
were no changes to the LCSTs (p>0.05).  PEG grafted polymers had significantly higher 
LCSTs than PEG branched polymers for 7% PEG polymers prepared with [M]/[I]=20 
(p<0.01) and [M]/[I]=200 (p<0.05).   The 7% PEG grafted and 7% PEG branched 
polymers prepared with [M]/[I]=600 had statistically similar LCSTs (p>0.05). 
 Figure 4.11 shows a plot of ΔH versus % PEG for both PEG grafted and PEG 
branched PNIPAAm.  As expected, the heat of the LCST transition (ΔH) decreased with 
increasing PEG content.  The 2.2% PEG branched polymer had significantly lower ΔH 
than pure PNIPAAm (p<0.05) however, the ΔH for the 3.6% PEG branched and pure 
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PNIPAAm polymers were statistically similar (p>0.05).  The 7% PEG branched polymer 
and 7% PEG grafted polymers had significantly lower ΔH values than the pure 
PNIPAAm (p<0.05 and p<0.001 respectively).   The ΔH  values of 7% PEG branched 
and 7% PEG grafted polymers were statistically similar (p>0.05).  The 31% PEG grafted 
polymer had only a slight shallow depression to mark the LCST making a calculation of 
ΔH impossible.  The value was taken to be 0.  The 31% PEG branched polymer had a 
measurable ΔH that was significantly lower than that of the pure PNIPAAm polymer 
(p<0.001).  By itself, PEG does not exhibit an LCST and therefore does not give off heat 
during the precipitation transition.  The heat measured per gram of solution showed 
decreases in ΔH (Figure 4.11).  The same decrease in ΔH with %PEG was seen when the 
ΔH was reported on a per gram basis of PNIPAAm alone (Figure 4.12) as has also been 
reported previously [274].    
 For each polymer fraction tested, (0.01, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3), the LCSTs 
of 7% PEG grafted polymer and 7% PEG branched polymer were significantly higher 
than that of pure PNIPAAm (p<0.05) (Figure 4.13).  The 7% PEG grafted polymers had 
significantly higher LCSTs than 7% PEG branched for polymer fractions of 0.01 
(p<0.01), 0.05 (p<0.05), 0.15 (p<0.01), 0.20 (p<0.001), and 0.30 (p<0.005).  LCSTs of 
the 7% PEG grafted and 7% PEG branched polymers were statistically similar for 
polymer fractions of 0.10 (p>0.05) and 0.25 (p>0.05).  LCST did not appear to be 
dependent on the polymer fraction of the solution (Figure 4.13).  Only a slight increase in 
LCST was noted when the polymer fraction was lowered to 0.01.  The ΔH of the LCST 
transition was naturally dependent on polymer fraction as the value is calculated on a per 
mass basis (Figure 4.14).  The relationship seemed linear between the polymer fractions 
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of 0.01-0.2.  After 0.2, the ΔH for each of the three polymers tested did not change as 
appreciably as it did within the lower range of polymer fraction (<0.02).  
4.4 Discussion 
 The polymerization of PNIPAAm with PEG grafts and PEG branches has been 
confirmed in part with ATR-FTIR and 1H-NMR studies.  IR-spectroscopy, though 
limited in quantifying PEG content in the polymers tested, was useful in monitoring the 
consumption of monomer in the polymerization reaction.  Observations that the more 
heavily branched polymers (molar %  PEG ≥ 7%) exhibited more gel-like reaction 
mixtures indicated that the PEG branching in these polymers was sufficient to create 
network-like structures swellable in methanol.  In 25% aqueous solutions, the more 
heavily branched polymers showed similar gel-like properties.  Dissolving the 31% PEG 
branched polymer to make a 25% aqueous solution resulted in a gel that easily crumbled.  
This could indicated that the water saturation level of these polymer is above 25%.   
 The higher values of intrinsic viscosity for PEG branched PNIPAAm were the 
result of more inter-connected polymer networks that rely on covalent bonds to link 
PNIPAAm chains instead of just secondary forces and entanglements, as with the PEG 
grafted PNIPAAm.  For PNIPAAm with 7% PEG grafts, the increase in intrinsic 
viscosity and estimated vM  with increasing [M]/[I] was expected.  It has been shown 
that kinetic chain length ( nX ) for free radical polymerization is proportional to the ratio 
of [M]/[I]1/2 as shown in Equation 4.8 [157]:  
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n =         Equation 4.8 
where kp, kt, and kd are rate constants for chain propagation, termination, and initiator 
decomposition.  f is the fraction of initially formed radicals that actually start growing 
chains and ξ is the average number of dead chains formed per termination.  Longer 
chains created with higher [M]/[I] ratios naturally exhibited higher intrinsic viscosities 
because of increased chain entanglements.  For PNIPAAm with 7% PEG branches, 
polymers prepared with [M]/[I]=200/1 and 600/1 were too viscous to be accurately tested 
with capillary viscometry.  The covalent linkages in these branched polymer networks 
result in much higher average molecular weights than the pure PNIPAAm or PEG grafted 
PNIPAAm polymers.     
 The viscosity average molecular weights ( vM ) values calculated with the Mark-
Houwink-Sakurada equation should be treated as only estimates.  Fujishige’s tests were 
conducted on monodisperse fractions of pure PNIPAAm [273].  In the studies presented 
here, the polydispersity of the polymers are unknown.  Furthermore, the introduction of 
PEG to the polymer system, in grafted and to a greater extent, branched structures will 
change the K and a constants that link [η] with vM .  Also, Fujishige reported the Mark-
Houwink-Sakurada relationship as linking [η] to number average molecular weight ( nM ) 
instead of viscosity average molecular weight ( vM ) as shown in Equation 4.9 [273]: 
[ ] anMKη =          Equation 4.9 
It is unclear as to whether that discrepancy with the traditionally written Mark-Houwink-
Sakurada equation was intentional or not.  The polydispersity of the standard PNIPAAm 
from Sigma Aldrich is unknown, making it difficult to access the accuracy of the 
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vM value of 75,000 determined by capillary viscometry.  For the most probable 
distribution (Schulz-Flory) in a theta (θ) solvent, polymer molecular weights can be 
defined by the relationship in Equation 4.10 [157]: 
2  :  1.67  :  1M  :M  :M wvn =       Equation 4.10 
This relationship is a safe assumption for the pure PNIPAAm polymers in water because 
the value of the constant a determined by Fujishige was 0.50, which is a typical value for 
when a polymer is in a θ-solvent [157]. 
 Polymers with moderate concentrations of PEG grafts or branches (PEG ≤ 7%) 
exhibited LCSTs that fell within the temperature range suitable for an injectable soft 
tissue replacement (25-37°C).  Additions of PEG to PNIPAAm imparted more 
hydrophilicity to the polymer, causing the LCST of the solutions to increase.  The 31% 
PEG polymers (both branched and grafted) exhibited LCSTs that were too high for the 
application of the nucleus pulposus.  A decrease in heat of transition per gram of solution 
with increasing concentration of PEG grafts and branches (shown in Figure 4.11) was 
expected because PEG rich polymers contained less thermogelling material.  The 
shallowness of the endotherm for the 31% PEG grafted polymer indicates that this coil to 
globule transition for this polymer was weak was not drastic.  This is likely due to 
presence of too many PEG grafts.  Figure 4.12 shows that the reduction in heat of 
transition with increasing PEG content, shown in Figure 4.11, was not solely based on the 
inability of PEG to transition thermally.  Instead of being just a non-thermally responsive 
filler, PEG chains, in both the grafted and branched structures, actually play a role in 
reducing the heat of the LCST transition.   
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 The LCST of PNIPAAm based polymers is not as sensitive to polymer fraction as 
depicted in schematic phase diagrams in polymer textbooks.  This has been previously 
reported by Sánchez et al. with DSC experiments on pure PNIPAAm in aqueous 
solutions [277].    There were slight increases in LCST when solution polymer fraction 
was lowered to 0.01, however cohesive hydrogels do not form at concentrations this low.  
The dependence of ΔH of the LCST transition on polymer fraction calculated on a per 
mass basis is expected.  However, the increases in ΔH above polymer fractions of 0.20 
are not as substantial and therefore could indicate some sort of change in transition 
behavior.  Sánchez et al. reported a maximum in ΔH for pure PNIPAAm with a polymer 
fraction of 0.07 [277].  A similar maximum was not observed with this study.  The 
influence of polymer fraction on the LCST and ΔH of the LCST above 0.30 is difficult to 
determine with the 7% PEG branched polymers, because they form thick heterogeneous 
solutions at higher polymer fractions.   
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Table 4.1 Matrices of polymers created by varying [NIPAAm]/[PEG] ratios and 
[NIPAAm]+[PEG]/[AIBN] ratios 
 20 200 600 
1/0 (All NIPAAm)  3  
300/1  3 3 3 
50/1  3  
 
 
 
 
 
 
 
 20 200 600 
1/0 (All NIPAAm)  3  
1000/1  3  
600/1  3  
300/1 3 3 3 
50/1  3  
 
 
 
 
 
 
 
 
 
 
[NIPAAm] 
/ [PEGM] 
 
 
[NIPAAm] 
/ [PEGDM] 
[NIPAAm]+[PEGDM] / [AIBN] 
[NIPAAm]+[PEGM] / [AIBN] 
PNIPAAm with PEG grafts 
PNIPAAm with PEG branches
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Table 4.2 Matrices of polymers created by varying molar % PEG and 
[NIPAAm]+[PEG]/[AIBN] ratios 
 20 200 600 
0  3  
7  3 3 3 
31  3  
 
 
 
 
 
 
 
 20 200 600 
0  3  
2.2  3  
3.6  3  
7 3 3 3 
31.3  3  
 
 
 
 
 
 
 
 
 
 
[NIPAAm]+[PEGDM] / [AIBN] 
[NIPAAm]+[PEGM] / [AIBN] 
PNIPAAm with PEG grafts 
PNIPAAm with PEG branches 
 
Molar % PEG 
 
Molar % PEG 
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Table 4.3 Results of 1H-NMR experiments to confirm copolymer compositions  
Theoretical Experimental (1H-NMR) 
Polymer Type 
[I]
[M]  
[PEG]
[NIPAAm]  Molar % PEG 
[PEG]
[NIPAAm]  Molar % PEG 
Homopolymer 200/1 1/0 0 1/0 0 
Grafted 20/1 300/1 7.0 305/1 6.9 
Grafted 200/1 300/1 7.0 302/1 7.0 
Grafted 600/1 300/1 7.0 311/1 6.8 
Grafted 200/1 50/1 31.3 50/1 31.3 
Branched 200/1 1000/1 2.2 959/1 2.3 
Branched 200/1 600/1 3.6 616/1 3.6 
Branched 20/1 300/1 7.0 323/1 6.6 
Branched 200/1 300/1 7.0 298/1 7.1 
Branched 600/1 300/1 7.0 266/1 7.9 
Branched 200/1 50/1 31.3 55/1 29.2 
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Table 4.4 Values of intrinsic viscosity [η] (mL/g) determined by capillary 
viscometry 
 20 200 600 
0  39.1  
7  27.5 39.4 45.8 
31  43.3  
 
 
 
 
 
 
 
 20 200 600 
0  39.1  
2.2  53.5  
3.6  69.6  
7 75.0 X X 
31.3  X  
 
 
 
 
 
 
 
 
 
 
 
[NIPAAm]+[PEGDM] / [AIBN] 
[NIPAAm]+[PEGM] / [AIBN] 
PNIPAAm with PEG grafts 
PNIPAAm with PEG branches 
 
Molar % PEG 
 
Molar % PEG 
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Table 4.5 Values of vM  (g/mol) calculated using the Mark-Houwink-Sakurada 
equation and intrinsic viscosities determined by capillary viscometry 
 20 200 600 
0  73K  
7  36K 74K 100K 
31  89K  
 
 
 
 
 
 
 
 20 200 600 
0  73K  
2.2  136K  
3.6  233K  
7 267K X X 
31.3  X  
 
 
 
 
 
 
 
[NIPAAm]+[PEGDM] / [AIBN] 
[NIPAAm]+[PEGM] / [AIBN] 
PNIPAAm with PEG grafts 
PNIPAAm with PEG branches 
 
Molar % PEG 
 
Molar % PEG 
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Figure 4.1 Schematic of polymerization reaction for PNIPAAm with PEG grafts 
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Figure 4.3 ATR-FTIR spectra illustrating the extent of a free radical 
polymerization of NIPAAm with PEGM 1000 over 2 days at 65°C 
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Figure 4.4 Representative sample spectra from 1H-NMR experiments to 
determine ratio of [NIPAAm]/[PEG] from peak areas at 0.99 ppm and 
3.6 ppm 
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Figure 4.5 Ubbelohde capillary viscometer in constant temperature bath 
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Figure 4.6 Plots of reduced viscosity as a function of concentration with 
extrapolations to determine intrinsic viscosity for the polymers 
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Figure 4.7 Viscometry tests conducted on PNIPAAm with 7% branched 
polymers with [M]/[I]=200 and 600 resulted in inconsistent results.  
Appreciably increased reduced viscosities were observed. 
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Figure 4.8 Representative DSC plot defining the LCST and ΔH of the transition 
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Figure 4.9 LCST values as a function of molar % PEG as determined by DSC 
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Figure 4.10 LCST values as a function of [M]/[I] as determined by DSC 
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Figure 4.11 ΔH values as a function of molar % PEG calculated per mass of 
polymer solution 
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Figure 4.12 ΔH values as a function of molar % PEG calculated per mass of 
PNIPAAm in each polymer 
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Figure 4.13 Effect of polymer fraction on the LCST of polymers in aqueous 
solution 
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Figure 4.14 Effect of polymer fraction on the ΔH of the LCST transition for  
polymers in aqueous solution 
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5 In Vitro Studies (Effect of PEG content and [M]/[I]) 
5.1 Introduction 
 Immersion studies were conducted to determine the long term swelling properties 
and stability of hydrogels.  For the studies presented in this chapter, 25% polymer 
solutions were heated to body temperature to create hydrogels.  Two immersion studies in 
buffered saline solution are presented.  In addition, the unconfined compressive 
mechanical properties were determined over immersion time. 
 A convenient way to characterize the swelling of the hydrogel is by monitoring its 
wet mass over immersion time and calculating a mass swelling coefficient, q(t).  This 
value can be calculated by Equation 5.1: 
(0)m
(t)m
q(t)
dry
gel=          Equation 5.1 
where mgel(t) is the mass of a wet hydrogel after an immersion time and mdry(0) is the 
initial dry mass of the polymer prior to swelling.  The value of mdry(0) used for these 
swelling studies was calculated by multiplying the known mass of the solution injected 
into the vial, msoln(0), by the polymer fraction that was used in prepared the solution (for 
these studies, the polymer mass fraction was 0.25).  This relationship is shown in 
Equation 5.2: 
(0)m0.25(0)m solndry ×=         Equation 5.2 
The hydrogel swelling can also be characterized by monitoring its water content over 
immersion time.  This can be done by drying the hydrogel after a set time of immersion 
and comparing its wet mass to its dry mass.  Water content can be calculated by Equation 
5.3: 
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100%
(t)m
(t)m(t)m
 (t)Content  Water %
gel
drygel ×−=      Equation 5.3 
where mdry(t) is the dry mass of a hydrogel after immersion for a given time.   
 With hydrogels, it is important to characterize the dissolution of polymer out of 
the hydrogel and into the immersion media.  Percent dissolution is the percentage of 
polymer that does not remain within the hydrogel after immersion and can be calculated 
by a comparison of the mdry(0) and mdry(t) Equation 5.4: 
( )
(0)m
(t)m-(0)m
tn dissolutio %
dry
drydry=        Equation 5.4 
In addition, chemical comparison can be conducted on the dried hydrogel after 
immersion and the same polymer prior to immersion.  This method allows determination 
of whether specific components or copolymers in the hydrogel system are selectively 
leaching out of the hydrogel during swelling.   
5.2 Experimental 
5.2.1 Swelling Studies 
 Known masses of 25% polymer solutions (prepared as described in Section 4.2.5)  
were aliquotted into 20 mL glass vials that were then sealed and placed in a 37°C water 
bath for 24 hours.  The resulting precipitated hydrogels were removed from their vials, 
weighed on a balance, and placed in 20 mL vials of Dulbecco’s Phosphate Buffered 
Saline solution (PBS, Sigma-Aldrich, pH=7.4) at 37°C.  The vials containing the 
hydrogels in solution were placed in a 37°C water bath.   
5.2.1.1 Swelling Study #1 
 In swelling study #1, six vials for each hydrogel sample were removed and the 
hydrogels were weighed after 1, 2, 4, 7, 10, 14 days and weekly thereafter until 90 days 
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of immersion.  Care was taken to not let the PBS solutions drop below 37°C as the 
hydrogel masses were being measured.  The PBS solution in the vials was changed 
initially every 2 days and weekly after equilibrium swelling was reached.   
After 90 days of immersion, the hydrogels were removed from their vials and 
weighed.  The hydrogels were placed in polystyrene cups that were dried in an incubator 
at 85°C and then freeze dried to fully remove water.  Upon complete drying, the dried 
hydrogels were then weighed.  Some of the dried hydrogels were then ground into 
powders.  These powders were analyzed with 1H-NMR in the manner described in 
Section 4.2.3.  
5.2.1.2 Swelling Study #2 
 Swelling study #2 was similar to swelling study #1 except that after being 
weighed on the balance, the hydrogels were not returned to the water bath for further 
mass measurements.  Six unique hydrogels samples for each polymer solution were 
removed from their vials, weighed, and dried to determine their dry masses after initial 
precipitation (t=1 day) and 1, 2, 4, and 8 weeks of immersion in PBS at 37°C.  PBS 
solution in the vials was changed initially every 2 days and weekly after equilibrium 
swelling was reached in the same manner as done in swelling study #1.   
5.2.2 Unconfined Compression Testing 
25% solutions for each polymer were filled into 15 mL polypropylene conical tubes 
having an inner diameter of 14.6 mm.  For the jelly-like solutions that did not pour easily, 
a centrifuge was used to aid in the filling of the tubes.  To precipitate the polymers, the 
tubes were individually heated in a 42°C DI water bath for 5-10 minutes.  After 
precipitation, the tubes were cut to create cylindrical samples with a height between 10-
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12 mm.  The polymer hydrogels were removed from the cut polypropylene annular rings 
and placed in vials of PBS solution (pH=7.4) at 37°C.   
After the sample heights and diameters were measured with a caliper, unconfined 
compression tests with an Instron Model 3362 were performed on the samples after 1, 15, 
and 33 days of immersion in PBS at 37°C (n=6).  With this study, 1 day represented 1 
day of immersion in PBS.  From a 0.1N compressive preload, the cylindrical samples 
were compressed to 25% strain and then unloaded to the preload condition at a strain rate 
of 100% min-1.  Compressive modulus values were calculated for the hydrogels by 
finding the initial slope of the compression profile from 0-15% strain. 
5.2.3 Statistical Analysis 
For comparison of data sets, Minitab Statistical Analysis Software (Version 13.30) 
was used to conducted one-way analysis of variance (ANOVA) tests.  To determine 
statistical significance, a 95% confidence interval (p<0.05) was used.  The p value was 
reported to describe to characterize significance when the confidence interval was greater 
than 95%.   
5.3 Results 
5.3.1 Swelling Study #1 
 For swelling study #1, the wet mass at t=1day, mwet(1), represented the 
precipitated wet mass that had not yet been immersed in media.  All polymers processed 
in Chapter 4 were tested in this swelling study except for branched and grafted 
PNIPAAm polymers prepared with 31% PEG.  Heating of a 25% solution of the 31% 
PEG grafted PNIPAAm polymer failed to form a cohesive hydrogel at 37°C.  At 25°C, a 
25% solution of the 31% PEG branched PNIPAAm polymer was a brittle hydrogel-like 
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solid that did not flow.  At 37°C, the hydrogel became opaque but its consistency did not 
change.  In addition, further experiments were not conducted on these polymer containing 
31% PEG as their LCST values were determined to be too high for an injectable 
application (see Figure 4.9).   
 For the polymers tested in swelling study #1, equilibrium swelling was reached 
within 10-14 days immersion in PBS.  Figure 5.1 shows that the mass swelling 
coefficient of 7% PEG grafted PNIPAAm hydrogels initially had a higher mass swelling 
coefficient than pure PNIPAAm after precipitation at 1 day (p<0.005).  However after 
immersion, the swelling profiles were similar.  After 90 days of immersion, they had 
statistically similar mass swelling coefficients.  Branching with PEG chains also initially 
caused the precipitated hydrogels to hold onto more water from solution.  Figure 5.2 
shows that 7% PEG branched PNIPAAm hydrogels had greater initial mass swelling 
coefficients (p<0.001) than pure PNIPAAm hydrogels.  Branching with 2.2% and 3.6% 
PEG resulted in no significant increase in initial mass swelling coefficient over pure 
PNIPAAm (p>0.05).  After 90 days of immersion there were no observable difference in 
swelling between the 3.6% and 7% PEG branched PNIPAAm hydrogels and the 
PNIPAAm hydrogel.  Slightly higher swelling was observed, however, for the 2.2% PEG 
branched PNIPAAm hydrogel when compared to the PNIPAAm hydrogel (p<0.005).    
 For the 7% PEG grafted PNIPAAm hydrogels, increasing the [M]/[I] ratio from 
20 to 200 led to a significant increase in the initial mass swelling coefficient (p<0.001) 
and mass swelling coefficient after 90 days immersion (p<0.01) as shown in Figure 5.3.  
No detectable differences in swelling were observed throughout the duration of the 
swelling study when the [M]/[I] ratio was raised from 200 to 600, however (Figure 5.3).  
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With 7% PEG branched PNIPAAm hydrogels, the initial mass swelling coefficient was 
highest for [M]/[I]=200 (see Figure 5.4).  After 90 days of immersion in PBS, no 
differences were observed between [M]/[I] ratios of 20 and 200.  The 7% PEG branched 
hydrogels prepared with an [M]/[I]=20 had a higher swelling coefficient (q(90)=1.60) 
after 90 days immersion than the hydrogels prepared with an [M]/[I]=600 (q(90)=1.53) 
(p<0.05).  Though statistically higher, the increase in mass swelling coefficient would 
only correspond to an increase in water content from 34.6% to 37.5% assuming there to 
be no dissolution.   
 For [M]/[I]=20, hydrogels with 7% PEG branches had higher mass swelling 
coefficients than hydrogels with 7% PEG grafts throughout the swelling study, as shown 
in Figure 5.5 (p<0.001 at 90 days).  Higher mass swelling coefficients were measured for 
the hydrogels prepared with 7% PEG branches than 7% PEG grafts initially for 
[M]/[I]=200 (Figure 5.6) (p<0.001) and [M]/[I]=600 (Figure 5.7) (p<0.01) however these 
differences were not significant after 90 days of immersion.   
 After 90 days immersion in PBS, the PEG grafted hydrogels had water contents 
slightly higher than the pure PNIPAAm hydrogels as shown in Table 5.1 however no 
changes in water content were seen when [M]/[I] was varied for the 7% PEG grafted 
hydrogels.  Hydrogel dissolution was highest for grafted hydrogel with an [M]/[I]=20 
(10.8%).  For the PEG branched hydrogels, the 7% PEG hydrogel with [M]/[I]=200 had 
the highest water content after 90 days immersion however the dissolution of this 
hydrogel was 24.3% after 90 days immersion.  1H-NMR was successful in confirming the 
chemistries in the hydrogels did not change dramatically as a result of immersion in PBS 
for 90 days.   
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5.3.2 Swelling Study #2 
 The nomenclature for swelling study #1 and swelling study #2 were similar.  The 
wet mass at t=1day, mwet(1), represented the precipitated wet mass that had not yet been 
immersed in media.  For this study, values of water content were calculated along with 
each measurement to determine mass swelling coefficient.  Samples were not tested 
multiple times.  Instead, after measurement of its wet mass, a sample was dried to 
determine its dry mass and calculate its water content and percent dissolution.  In 
swelling study #2, the grafted and branched hydrogels prepared with [M]/[I]=20 were not 
tested because of small particulates that were observed in 25% solutions made from those 
copolymers. 
 For all the hydrogels tested, equilibrium swelling was reached after 14 days of 
immersion in PBS.  Immediately after precipitation, the mass swelling coefficient was 
higher for 7% PEG grafted hydrogels (both [M]/[I]=200 and [M]/[I]=600) than pure 
PNIPAAm hydrogels (Figure 5.8) however the differences observed were not statistically 
significant.  The 7% PEG grafted hydrogels with [M]/[I]=600 had significantly higher 
percent water content than pure PNIPAAm hydrogels after precipitation (Figure 5.9) 
(p<0.05).  After 56 days immersion in PBS, the mass swelling coefficients and % water 
contents of the 7% PEG grafted hydrogels ([M]/[I]=200 and [M]/[I]=600) were higher 
than those of the pure PNIPAAm hydrogel (p<0.001).  No differences in swelling were 
observed between 7% PEG grafted hydrogels produced with [M]/[I]=200 and 
[M]/[I]=600 at 56 days immersion.  For branched PEG hydrogels, the initial mass 
swelling coefficients and % water contents of the pure PNIPAAm, 2.2% and 3.6% PEG 
branched hydrogels were all statistically similar.  The 7% PEG branched hydrogels (both 
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[M]/[I]=200 and [M]/[I]=600) had higher initial mass swelling coefficients (Figure 5.10) 
and percent water contents (Figure 5.11) than pure PNIPAAm hydrogels initially after 
precipitation (p<0.001).  After 56 days of immersion, addition of 2.2% and 3.6% PEG 
branches to the pure PNIPAAm hydrogel resulted in a minimal but statistically 
significant increase in mass swelling coefficient and water content as shown in Figure 
5.10 and Figure 5.11 (p<0.001).  As with the 7% PEG grafted hydrogels, the 7% PEG 
branched hydrogels also had higher mass swelling coefficients and water contents than 
the pure PNIPAAm hydrogels after 56 days immersion in PBS (p<0.001).  A comparison 
of water content values over the 56 days immersion period for PNIPAAm, 7% PEG 
grafted and 7% PEG branched hydrogels is shown in Figure 5.12. 
 The only deviations between measurements of mass swelling coefficient and 
water content occur when there are polymer chains eluting out of the hydrogel.  At t=1 
day, the value of percent dissolution represents the dry mass of the hydrogel collected 
after 24 hours left in the vial, without any PBS added.  Figure 5.13 shows the dissolution 
of the PEG grafted hydrogels over 56 days of immersion in PBS.  At each time point, 
differences among the dissolution values were minimal.  After precipitation (t=1 day), 
7% PEG grafted hydrogels, showed significantly less dissolution than pure PNIPAAm 
hydrogels (p<0.01).  Dissolution increased significantly between 1 day and 7 days 
(p<0.01).  Only minimal changes were seen after 7 days immersion in PBS.  After 56 day 
immersion, the 7% PEG grafted hydrogel with [M]/[I]=600 had less dissolution than the 
pure PNIPAAm hydrogel (p<0.05).   
 For the PEG branched hydrogels, higher variations were seen with percent 
dissolution, especially for 7% PEG branched hydrogels (Figure 5.14).  After 56 days of 
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immersion, small but statistically significant decreases were seen when 2.2% and 3.6% 
PEG branches were added to pure PNIPAAm hydrogels (p<0.01).  Dissolution of the 7% 
PEG branched hydrogel ([M]/[I]=600) was significantly less than that of the PNIPAAm 
hydrogel (p<0.001) and that of the 7% PEG branched hydrogel produced with 
[M]/[I]=200 (p<0.01). 
5.3.3 Unconfined Compression Testing 
 For the unconfined compression tests, values reported at t=1 day represent 
measurements conducted 1 day after immersion in PBS instead of measurements made 1 
day after heating to 37°C.  Representative plots of stress vs. strain for the hydrogels 
tested are found in Figure 5.15.  The initial slope of each response was relatively linear 
between 0-15%.  Compressive modulus values were measured as the slope of this initial 
region as shown in Figure 5.16.  During the controlled unloading of each hydrogel, the 
moving crosshead lost contact with the sample.  When this occurred, the load cell 
measurement indicated a stress level that fell below 0.1 kPa, effectively representing no 
load being measured by the load cell.  The strain level at which the moving crosshead lost 
contact with the sample was referred to as δ and is depicted on a typical stress/strain plot 
in Figure 5.16.   
 The compressive modulus values for the hydrogels tested increased between 1 
day and 15 days of immersion in PBS (Figure 5.17) (p<0.05).  Between 15 and 33 days 
of immersion however, no statistically significant changes were observed in compressive 
modulus for the hydrogels.  After 33 days of immersion in PBS, 7% PEG grafted and 7% 
PEG branched hydrogels had lower compressive moduli (17.8 kPa and 24.1 kPa 
respectively) than the PNIPAAm hydrogel (36.4 kPa) (p<0.005).   
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 Measurement of δ, the strain level at which the moving crosshead lost contact 
with the sample, is a way to quantify the dimensional recovery of a hydrogel as it’s being 
unloaded.  Lower values of δ describe a hydrogel with a higher amount of elastic 
recovery.  For most hydrogels, values of δ remained relatively constant over 33 days of 
immersion in PBS (Figure 5.18).  However, a significant change was observed between 1 
and 15 days of immersion in PBS for the 7% PEG branched hydrogel (p<0.001)  
Additions of 2.2% PEG branches and 3.6% PEG branches to pure PNIPAAm resulted in 
significant decreases in δ (p<0.05).  The δ values for the 7% PEG grafted hydrogels were 
significantly higher than those of the pure PNIPAAm hydrogel (p<0.001).  The lowest δ 
value at each time point was observed for 7% PEG branched hydrogels.   
5.4 Discussion 
 The purpose of swelling study #2 was to determine whether the high dissolution 
percentages calculated in swelling study #1 after 90 days of immersion were accurate.  It 
appears that the method of repeatedly measuring the mass of a sample in an environment 
below its LCST is prone to error.  During the mass measurement process, the surface of a 
hydrogel that comes in contact with the room temperature surface of the balance lowers 
in temperature.  If the hydrogel surface reaches a temperature below its LCST, polymer 
can partially dissolve and attach to the surface of the balance.  If a similar loss in surface 
mass is repeated with measurements at various times, the mass of the hydrogel could 
become appreciably lower over immersion time.  This polymer loss causes the 
calculation of mass swelling coefficient to be inaccurate because measurement of the dry 
mass of the hydrogel is “changing” over time.  It is no coincidence that the polymer with 
the lowest LCST had the lowest dissolution percent after 90 days.   
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 Differences in swelling were observed after short immersion times with higher 
PEG contents leading to higher q values.  This was seen with swelling studies #1 and #2.  
In swelling study #2, hydrogels with higher PEG graft and PEG branch concentrations 
had enhanced swelling after equilibrium swelling was reached.  This was not observed 
with swelling study #1 where q values were not as sensitive to PEG content over longer 
immersion times.  However, after 90 days of immersion, hydrogels with higher PEG 
contents had higher water content which supports the theory of polymer dissolving as a 
result of measurement technique.   
 PEG grafts are not as effective as PEG branches in raising the water content of 
PNIPAAm hydrogels.  The PEG grafted hydrogels have clusters of physically associated 
PNIPAAm chains through interactions and entanglements.  PEG grafts are effective in 
raising the water content of pure PNIPAAm hydrogels after 56 days of immersion in PBS 
(39.5% water for 7% PEG grafts vs. 29.3% for pure PNIPAAm), however not to the 
extent that PEG branches do (47.7% for 7% PEG branches), as shown in Figure 5.12.  By 
branching the structure, a porous network likely forms, that can hold onto and entrap 
water.   
 Water content of the hydrogels was not enhanced appreciably when the [M]/[I] 
ratio was raised from 200 to 600.  With branched networks, the swelling may not be 
sensitive to the [M]/[I] ratio because the polymer chains are interconnected and the 
network properties are dominated by the frequency of crosslinks as seen when PEG 
branch content was increased from 2.2% to 3.6% to 7%.  With PEG branched PNIPAAm 
hydrogels, raising the [M]/[I] from 200 to 600 only lengthens the PNIPAAm chains 
which could increase entanglements.  Grafting only has the potential to increase the 
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physical interactions between the chains, not create porous network like structures 
capable of holding onto water.   
 Dissolution of the grafted and branched hydrogels (determined in swelling study 
#2) does not seem to be highly dependent on hydrogel composition (Figure 5.13 and 
Figure 5.14).  Some negative dissolution percentages were observed for the branched 
hydrogels and the standard deviations for some of the samples were quite high.  Negative 
dissolution percentages could be due to uptake of ions into the hydrogel networks.   Ho 
has shown with Electron Dispersive X-Ray Analysis (EDXA) that when crosslinked 
PNIPAAm-PEGDM hydrogels are dried after swelling in ionic immersion media, a 
deposition of ions are found throughout the hydrogel network [278].  An increase in dry 
mass of PVA/PVP hydrogels has also been shown by EXDA to be due to ion uptake 
[135].  An uptake of ions would effectively increase the perceived dry polymer mass.  
Negative dissolution values could also be due to error in measurement of the sample 
masses.  Since the dissolution percent of the hydrogels did not drastically change between 
7 and 56 days of immersion it can be surmised the a nominal amount of mass loss that is 
measured for each hydrogel is the result of polymer that is lost by sticking to the inside of 
the vial surface and not the elution of polymer chains from a hydrogel network over time. 
 The chemical stability of the hydrogels over 90 days immersion in PBS was 
shown with 1H-NMR.  Though a sample size of two was used for each hydrogel after 90 
days of immersion in PBS, the measured PEG contents did not vary widely before or 
after immersion in PBS.  Slight variations in the NMR results are likely due to human 
error in determining the baselines peak area measurements for the PEG content 
calculation.  Assuming these variations to be minimal, it is possible to conclude that they 
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ratio of PNIPAAm/PEG in the hydrogels is not changing.  Specific components of the 
copolymer hydrogels (PNIPAAm and PEG) are not selectively leaching out of the 
hydrogel during in vitro experiments.   
  The stiffness of the hydrogels tested decreased with increasing water content as 
shown previously [137, 138].  Cadaveric testing and mathematical modeling have shown 
that a nucleus replacement with a compressive modulus of 50 kPa is able to restore 
healthy tension in the annulus fibers [279].  Small additions of PEG branches to the 
PNIPAAm hydrogel (2.2% and 3.6% PEG) only increased the water content by 3% for 
each hydrogel.  Though statistically significant, the increases in water content were too 
small to result in any appreciable difference in compressive modulus.  Pure PNIPAAm, 
2.2% and 3.6% PEG branched PNIPAAm hydrogels have compressive modulus values 
between 35-45 kPa.  Though these hydrogels have stiffness values that approach 50 kPa, 
they do not elastically recover from compressive deformations, making them ill-suited as 
materials for a replacement of the nucleus pulposus.   
 Additions of 7% PEG grafts and 7% PEG branches to PNIPAAm equally reduce 
the stiffness of the hydrogels to values between 15-25 kPa.  Covalently connected 
networks formed with sufficient PEG branching are able to elastically recovery upon 
unloading, while the physical interactions responsible for linking PNIPAAm chains in the 
PEG grafted hydrogels can disentangle with compressive deformations.  These 
disentanglements effectively result in a permanent change in the shape of the hydrogel.   
 The viscoelastic nature of the disc allows it to have time-dependent responses to 
mechanical loads.  Compressive loading of the disc in creep or fatigue results in 
temporary loss in disc height.  After these types of loading regimes, the dimensional 
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recovery of the disc (especially disc height) is important for maintaining a healthy tension 
in the annulus layers. For a nucleus pulposus replacement, the ability of the material to 
elastically recovery from mechanical loads is equally important in maintaining the 
function of the disc.  From measurements of δ, the strain level at which the moving 
crosshead lost contact with the sample, for pure PNIPAAm and PEG grafted PNIPAAm 
hydrogels, one compression and unloading cycle on these hydrogels would essentially 
result in a permanent change in the size of the implant.  Because they are not covalently 
linked networks, these hydrogels lack the short-term elastic recovery required for more 
aggressive mechanical loading.  Compression cycles on these materials would just further 
flatten them.  The elastic recovery exhibited by the 7% PEG branched hydrogel more 
closely matches that of the native nucleus, allowing it to possibly serve as a nucleus 
replacement.   
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Table 5.1 Swelling and chemical analysis results for copolymer hydrogels after 
90 days immersion in PBS 
Swelling after 90 days 
Immersion in PBS      
(AVG ± STDEV) 
Molar % PEG (1H-NMR) 
Polymer Type 
[I]
[M]  
[PEG]
[NIPAAm]
% Water 
Content 
% 
Dissolution 
Before 
Immersion 
After 90 day 
Immersion in 
PBS 
Homopolymer 200/1 0 35.2 ± 1.8 0.5 ± 1.5 0 0 
Grafted 20/1 7.0 38.2 ± 1.2 10.8 ± 1.4 6.9 6.8 
Grafted 200/1 7.0 38.7 ± 1.6 6.3 ± 1.4 7.0 6.9 
Grafted 600/1 7.0 39.0 ± 2.9 4.4 ± 1.0 6.8 6.9 
Grafted 200/1 31.3 X X 31.3 X 
Branched 200/1 2.2 41.7 ± 2.0 2.8 ± 0.4 2.3 2.3 
Branched 200/1 3.6 36.2 ± 2.6 3.0 ± 0.7 3.6 3.7 
Branched 20/1 7.0 43.3 ± 2.0 9.2 ± 0.8 6.6 7.0 
Branched 200/1 7.0 53.9 ± 2.2 24.3 ± 2.9 7.1 7.3 
Branched 600/1 7.0 44.5 ± 1.5 15.5 ± 0.9 7.9 7.5 
Branched 200/1 31.3 X X 29.2 X 
 
 
 
 
 
  112
1.0
1.2
1.4
1.6
1.8
2.0
0 20 40 60 80 100
Time (days)
q 
(w
et
 m
as
s 
/ i
ni
tia
l d
ry
 p
ol
ym
er
 m
as
s)
 0 (PNIPAAm) 7
% PEG grafts
 
Figure 5.1 Mass swelling coefficient for grafted hydrogels in PBS ([M]/[I]=200) 
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Figure 5.2 Mass swelling coefficient for branched hydrogels in PBS ([M]/[I]=200) 
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Figure 5.3 Mass swelling coefficient for grafted hydrogels in PBS (7% PEG) 
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Figure 5.4 Mass swelling coefficient for branched hydrogels in PBS (7% PEG) 
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Figure 5.5 Mass swelling coefficient for 7% PEG hydrogels in PBS ([M]/[I]=20) 
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Figure 5.6 Mass swelling coefficient for 7% PEG hydrogels in PBS ([M]/[I]=200) 
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Figure 5.7 Mass swelling coefficient for 7% PEG hydrogels in PBS ([M]/[I]=600) 
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Figure 5.8 Mass swelling coefficient for grafted hydrogels in PBS 
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Figure 5.9 Percent water content for grafted hydrogels over 56 days immersion 
in PBS 
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Figure 5.10 Mass swelling coefficient for branched hydrogels in PBS 
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Figure 5.11 Percent water content for branched hydrogels over 56 days of 
immersion in PBS 
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Figure 5.12 Comparison of percent water content pure PNIPAAm, 7% PEG 
grafted, and 7% PEG branched hydrogels over 56 days of immersion 
in PBS. 
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Figure 5.13 Percent dissolution for grafted hydrogels over 56 days of immersion in 
PBS 
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Figure 5.14 Percent dissolution for branched hydrogels over 56 days of immersion 
in PBS 
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Figure 5.15 Representative stress/strain plots for PNIPAAm copolymer hydrogels 
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Figure 5.16 Representative stress/strain plot for PNIPAAm based hydrogels 
showing how compressive modulus and the strain level at which the 
sample lost contact with the crosshead were calculated 
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Figure 5.17 Compressive modulus values determined by measuring the slope from 
0-15% for the stress-stress response for PNIPAAm copolymer 
hydrogels over 33 days of immersion in PBS 
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Figure 5.18 Strain values at which PNIPAAm copolymer hydrogels lost contact 
with the crosshead over 33 days of immersion in PBS 
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6 Effect of Osmotic Pressure 
6.1 Introduction 
 Fluid flow in the intervertebral disc forms from the balance between hydrostatic 
pressures due to mechanical loads and swelling pressures that arise from macromolecules 
found in the nucleus [13].  As discussed in Section 2.1.2, the nucleus environment has an 
osmotic pressure that stems from sulfated glycosaminoglycans (GAGs) that are found on 
proteoglycan macromolecules, the most abundant dry component within nucleus.  
Because of their fixed negative charge, GAGs are responsible for the existence of an 
osmotic pressure within the nucleus that ranges between 0.1-0.3 MPa [10, 13].  
Proteoglycans balance the dehydration that occurs due to mechanical loading by imbibing 
water from surrounding tissue during low loading conditions such as resting supine [14, 
15].  During the daily functional loading (walking, sitting) the mechanical loading causes 
a liberation of water molecules which results in a loss of approximately 25% of the water 
volume in the disc on a daily basis.  Adams and Hutton have shown up to a 20% loss in 
disc fluid can occur over 4 hours of loading in vitro [280].   
 For candidate replacement materials for the nucleus pulposus, it is important to 
determine the effect that the osmotic pressure will have on the implant once it is placed in 
situ.  There will be an osmotic competition between the hydrophilic hydrogel and the 
hydrophilic GAGs with both materials in close proximity.  Potentially, the osmotic 
pressure of the nucleus environment could absorb water from the implant just as it 
absorbs water under normal physiological conditions.  Dehydration of the hydrogels 
presented in this work would drastically change their mechanical properties, just as 
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dehydration affected the mechanical properties of PVA/PVP hydrogels [138] as well as 
the mechanical behavior of the disc itself [281].      
 In this study, the effect of a simulated osmotic environment has on the swelling of 
the PNIPAAm and PNIPAAm copolymer hydrogels was evaluated.  Urban and Maroudas 
have shown that the osmotic environment can be replicated by swelling disc tissue in 
aqueous solutions of PEG having a Mw=20,000 g/mol [282, 283].  The relationship that 
they reported between osmotic pressure and concentration of PEG solution is shown in 
Figure 6.1.  For this swelling study, we chose to replicate an osmotic pressure of 0.15 
MPa, which is between the reported values of 0.1-0.3 MPa.  By using the relationship 
curve presented by Urban and Maroudas (Figure 6.1), the immersion media used to 
replicate this pressure was determined to have a concentration of 0.12 g PEG (20K) / mL 
DI water.   
6.2 Experimental 
 Known masses of 25% polymer solutions (prepared as described in Section 4.2.5)  
were aliquotted into 20 mL glass vials that were then sealed and placed in a 37°C water 
bath for 24 hours.  The resulting precipitated hydrogels were removed from their vials, 
weighed on a balance, and placed in 20 mL vials of PEG solution at 37°C.  The aqueous 
PEG solution was made by adding Poly(ethylene glycol) (PEG, Polysciences, 
Mw=20,000g/mol) to DI water with a 0.12g PEG 20K / 1 mL H2O ratio and mixing to 
form a homogenous solution.  The vials containing the hydrogels in solution were placed 
in a 37°C water bath.   
 Six vials for each hydrogel sample were removed and the hydrogels were weighed 
after 1, 2, 4, 7, 10, 14 days and weekly thereafter until 90 days of immersion.  Care was 
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taken to not let the PEG solutions drop below 37°C as the hydrogel masses were being 
measured.  The PEG solution in the vials was changed initially every 2 days and weekly 
after equilibrium swelling was reached.   
After 90 days of immersion, the hydrogels were removed from their vials and 
weighed.  The hydrogels were placed in polystyrene cups that were dried in an incubator 
at 85°C and then freeze dried to fully remove water.  Upon complete drying, the dried 
hydrogels were then weighed.  Some of the dried hydrogels were then ground into 
powders.  These powders were analyzed with 1H-NMR in the manner described in 
Section 4.2.3.  
For comparison of data sets, Minitab Statistical Analysis Software (Version 
13.30) was used to conducted one-way analysis of variance (ANOVA) tests.  To 
determine statistical significance, a 95% confidence interval (p<0.05) was used.  The p 
value was reported to describe to characterize significance when the confidence interval 
was greater than 95%.   
6.3 Results 
 Mass swelling coefficients and percent water contents after 90 days immersion 
were calculated for the hydrogels swelled in PEG solution in the same manner as 
presented for the hydrogels swelled in PBS in Chapter 5.  As in swelling study #1, the 
wet mass at t=1day, mwet(1), represented the precipitated wet mass that had not yet been 
immersed in media.  In addition, all polymers processed in Chapter 4 were tested in this 
swelling study except for branched and grafted PNIPAAm polymers prepared with 31% 
PEG.  For comparative purposes with the results presented here, some swelling plots also 
show the swelling profiles determined in Chapter 5.   
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 Figure 6.2 shows that the mass swelling coefficient of 7% PEG grafted 
PNIPAAm hydrogels initially had a higher mass swelling coefficient than pure 
PNIPAAm after precipitation at 1 day (p<0.005).  However, after 90 days of immersion 
in PEG solution, the mass swelling coefficient of the pure PNIPAAm hydrogel was 
significantly higher than that of the 7% PEG grafted hydrogel (p<0.01).  Calculations  
after 90 days of immersion in PEG solution (Table 6.1) showed the two hydrogels to have 
similar water contents.  Pure PNIPAAm and the 7% PEG grafted hydrogel had water 
contents of 36.2% and 34.9%, respectively.   
 For the PEG branched hydrogels, swelling in PEG solution did not result in any 
differences in the swelling profiles among hydrogels made from pure PNIPAAm, and 
2.2% and 3.6% PEG branched PNIPAAm (Figure 6.3).  However the 7% PEG branched 
hydrogels had significantly higher mass swelling coefficient after precipitation (p<0.001) 
and 90 days of immersion in PEG solution (p<0.005).   
 When the [M]/[I] ratio of the 7% PEG grafted hydrogels was varied from 20 to 
200, (Figure 6.4) the only significant enhancement in the mass swelling coefficient of the 
hydrogels was observed immediately after precipitation.  Once swelled in PEG solution, 
the swelling profiles of 7% PEG grafted hydrogels with [M]/[I]=20 and [M]/[I]=200 were 
similar.  There was a significant increase in mass swelling coefficient when the [M]/[I] 
ratio was increased from 200 to 600 initially after precipitation (p<0.001) and after 90 
days of immersion in PEG solution (p<0.005).  The [M]/[I] ratio of 200/1 showed the 
highest mass swelling coefficient with the 7% PEG branched hydrogels initially and after 
90 days of immersion in PEG solution (Figure 6.5).  After 90 days of immersion in PEG 
solution, the swelling coefficients of 7% PEG branched hydrogels with [M]/[I]=20 and 
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[M]/[I]=200 were similar but hydrogels made with [M]/[I]=200 had a significantly higher 
swelling coefficient than hydrogels made with [M]/[I]=600 (p<0.005).   
 For each [M]/[I] ratio (20, 200, 600) comparisons of the swelling profiles of 7% 
PEG grafted and 7% PEG branched hydrogels were made.  These plots are found in 
Figure 6.6, Figure 6.7, and Figure 6.8.  For [M]/[I]=20 (Figure 6.6), immersion in PEG 
solution led to higher mass swelling coefficients after 90 days immersion than immersion 
in PBS for 7% PEG grafted hydrogels (p<0.001) and 7% PEG branched hydrogels 
(p<0.05).  For [M]/[I]=200 (Figure 6.7), there was a significant enhancement in mass 
swelling coefficient for 7% PEG branched hydrogels that were immersed in PEG solution 
(p<0.01).  The difference between swelling in PEG solution versus PBS was dramatic 
throughout the test.  After 90 day of immersion, the enhancement seen when swelling in 
PEG solution was significant but not as drastic (p<0.01).  No differences were observed 
in swelling for 7% PEG grafted hydrogels swelling in PBS and PEG solution (p>0.05).  
For [M]/[I]=600 (Figure 6.8), significant but minimal differences in swelling were 
observed between the immersion medias of PBS and PEG solution for 7% PEG grafted 
(p<0.05) and PEG branched (p<0.05) after 90 days of immersion. 
 For the comparison of the swelling profiles of pure PNIPAAm and 7% PEG 
grafted hydrogels in PBS and PEG solutions, the highest swelling coefficient was 
exhibited by pure PNIPAAm hydrogel swelled in PEG solution (Figure 6.9).  When the 
swelling profiles of the branched copolymer hydrogels in PBS and PEG solution were 
compared, the higher swelling coefficient was exhibited by the 7% PEG branched 
hydrogel swelling in PEG solution (Figure 6.10).   
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 The water contents of the hydrogels swelled in PEG solution for 90 days (Table 
6.1) were not appreciably different than those swelled in PBS for 90 days (Table 5.1).  
However, there were significant decreases in 90 day water content percentages for the 7% 
PEG branched hydrogels made with [M]/[I]=200 (p<0.001) and [M]/[I]=600 (p<0.001) 
when they were swelling in the PEG solution.  Negative dissolution percentages were 
observed for some of the hydrogels.  1H-NMR indicated that the PEG content of the 
hydrogels increased after 90 days of immersion in PEG solution.  For example, the pure 
PNIPAAm hydrogel had 4.1% PEG content (molar basis) after 90 days of immersion in 
PEG solution.  Before immersion in PEG solution, the PNIPAAm hydrogels prepared 
with 2.2% PEG branches showed a 2.3% PEG content.  However 90 days of immersion 
in PEG solution caused the PEG content of these hydrogels to increase to 30%.   
6.4 Discussion 
 It was expect that the simulated osmotic environment would decrease swelling in 
the hydrogels.  On the contrary, most of the hydrogels exhibited increased swelling in the 
osmotic PEG solution versus PBS.  It is possible that PEG in solution was attracted to the 
PEG covalently linked to PNIPAAm chains in the hydrogels and increased the swelling 
ratio of the hydrogels slightly as PEG is hydrophilic.  The most significant enhancement 
in swelling was shown for the 7% PEG branched hydrogel with [M]/[I]=200.  However 
the increase in swelling in PEG solution is not just due to the affinity of PEG chains in 
solution for covalently linked PEG chains.  This theory does not explain why the pure 
PNIPAAm hydrogel showed increased swelling in the osmotic PEG solution versus 
swelling in PBS.  In addition, the 7% PEG grafted hydrogel showed no increases in 
swelling in PEG solution while the 7% PEG branched hydrogel did (Figure 6.7).   
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 After 90 days of immersion, 7% PEG branched hydrogels with [M]/[I]=200 had 
lower water content when swelled in PEG solution (40.5%) than in PBS (53.9%).  These 
values seem counter-intuitive when reviewing the swelling profiles which would suggest 
a higher water content with this hydrogel swelling in the osmotic PEG solution.  
However, it is important to consider the basis for measurements of mass swelling 
coefficient and water content.   Measurement of q(t) is performed with respect to the 
theoretical initial dry mass of the hydrogel sample which before swelling is solely 
composed of the purified dry polymer.  Percent water content after 90 days of immersion 
is a measurement that can also take into account PEG chains that diffuse into the 
hydrogel over the immersion study and stay embedded in the hydrogel network when it is 
dried.  Incorporation of PEG chains from the concentrated solution of 20K PEG were 
confirmed with the negative dissolution values calculated after 90 days of immersion for 
some of the grafted and branched hydrogels.  In addition, 1H-NMR results further 
confirmed that the increases in dry mass are due to PEG chains from the PEG solution.  
The incorporation of free PEG chains into the hydrogel networks causes swelling 
calculations to be inaccurate.  It would be interesting to determine the degree to which the 
water content and dissolution percentages calculated in Chapter 5 were influenced by  
salts in PBS that deposited into the hydrogel, increasing the apparent polymer mass.   
 It is likely that the PEG solution prepared in this study was partly to blame.  PEG 
20K (Polysciences) that was used in this study has a reported MW range from 5K to 30K.  
Urban and Maroudas did not report polydispersity values for the PEG used to make their 
solutions [282, 283].  This detail is important because shorter PEG chains are better able 
to diffuse from the immersion media into the hydrogel networks.  The relationship 
  137
between osmotic pressure and PEG concentration is also likely to change with PEG 
polydispersity.   In addition, the PEG solutions used by Urban and Maroudas to obtain 
the relationship shown in Figure 6.1 also contained concentrations of NaCl while no salt 
was used in the current study [283].  This could also influence the osmotic pressures of 
the solutions. 
 Due to the uptake of PEG into the PNIPAAm copolymer hydrogels, it is 
impossible to assess the effect that a simulated osmotic environment would have on the 
PNIPAAm copolymer hydrogels from the experiments presented here.  For an 
experiment to accurately replicate osmotic pressure within the nucleus, free PEG chains 
must be prevented from penetrating the pores of the hydrogel.  Alternative methods to 
impart an osmotic pressure onto a hydrogel would include the use of dialysis bags or 
immersion in macromolecule solution that does not swell the hydrogel.  Osmotic 
pressures have also been created by swelling in concentrated solutions of Dextran [284, 
285].  Dextran is a larger macromolecule than PEG.  Its globular structure would be less 
likely to imbibe into the PNIPAAm copolymer hydrogels. 
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Table 6.1 Swelling and chemical analysis results for copolymer hydrogels after 
90 days immersion in osmotic PEG solution 
Swelling  after 90 days 
Immersion in PEG solution 
(AVG ± STDEV) 
Molar % PEG (1H-NMR) 
Polymer Type 
[I]
[M]  
[PEG]
[NIPAAm]
% Water 
Content 
% 
Dissolution 
Before 
Immersion 
After 90 day 
Immersion in 
PEG solution 
Homopolymer 200/1 0 36.2 ± 2.2 -5.8 ± 1.2 0 4.1 
Grafted 20/1 7.0 37.7 ± 1.2 6.1 ± 1.4 6.9 30.4 
Grafted 200/1 7.0 34.9 ± 2.6 2.7 ± 3.2 7.0 17.8 
Grafted 600/1 7.0 41.5 ± 1.5 2.4 ± 1.8 6.8 16.1 
Grafted 200/1 31.3 X X 31.3 X 
Branched 200/1 2.2 41.1 ± 4.1 -5.1 ± 2.4 2.3 30 
Branched 200/1 3.6 36.7 ± 1.7 -3.4 ± 1.9 3.6 11.6 
Branched 20/1 7.0 45.0 ± 4.6 3.0 ± 1.9 6.6 14.4 
Branched 200/1 7.0 40.5 ± 2.1 -13.5 ± 5.1 7.1 13.3 
Branched 600/1 7.0 37.1 ± 1.8 -3.6 ± 5.3 7.9 9.8 
Branched 200/1 31.3 X X 29.2 X 
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Figure 6.1 Relationship between osmotic pressure and concentration of aqueous 
PEG 20K solutions [282, 283].  
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Figure 6.2 Mass swelling coefficient for grafted hydrogels in osmotic PEG 
solution ([M]/[I]=200) 
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Figure 6.3 Mass swelling coefficient for branched hydrogels in osmotic PEG 
solution ([M]/[I]=200) 
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Figure 6.4 Mass swelling coefficient for grafted hydrogels in osmotic PEG 
solution (7% PEG) 
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Figure 6.5 Mass swelling coefficient for branched hydrogels in osmotic PEG 
solution (7% PEG) 
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Figure 6.6 Comparison of swelling profiles for 7% PEG grafted and 7% PEG 
branched hydrogels ([M]/[I]=20) swelling in PBS and osmotic PEG 
solutions 
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Figure 6.7 Comparison of swelling profiles for 7% PEG grafted and 7% PEG 
branched hydrogels ([M]/[I]=200) swelling in PBS and osmotic PEG 
solutions 
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Figure 6.8 Comparison of swelling profiles for 7% PEG grafted and 7% PEG 
branched hydrogels ([M]/[I]=600) swelling in PBS and osmotic PEG 
solutions 
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Figure 6.9 Comparison of swelling profiles for pure PNIPAAm and 7% PEG 
grafted  hydrogels ([M]/[I]=200) swelling in PBS and osmotic PEG 
solutions. 
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Figure 6.10 Comparison of swelling profiles for pure PNIPAAm and 2.2%, 3.6%, 
and 7% PEG grafted  hydrogels ([M]/[I]=200) swelling in PBS and 
osmotic PEG solutions. 
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7 Effects of Compressive Loading Cycles 
7.1 Introduction 
 Instead of evaluating the dynamic mechanical properties of hydrogels, some have 
sought to describe the mechanisms at the molecular level that are responsible for the 
mechanical properties.  Deformation of a hydrogel is complex.  There can be a reversible 
elastic response with non-permanent deformation of the hydrogel.  Non-reversible 
deformations that result from the break down of physical or chemical crosslinks, and/or 
the removal of water from the hydrogel [238].  In evaluating hydrogels as potential 
nucleus pulposus replacements, it is important to understand these mechanisms that 
govern deformation under dynamic loading conditions.   
 Takigawa et al. broke down the tensile stress relaxation of PNIPAAm hydrogels 
into three components or mechanisms:  elastomeric relaxation, relaxation due to the 
breakdown of physical crosslinks, and swelling-induced relaxation [238].   They 
compared results from tensile stress relaxation experiments in water and paraffin with a 
model that links swelling behavior of the hydrogels with its tensile relaxation properties.  
Discrepancies between their results and the model were the basis for assuming the 
existence of physical crosslinks [238].   Stauffer and Peppas studied PVA hydrogels in 
compressive creep experiments [286].  Using a dial comparator, they applied a known 
load and measured samples thickness as a function of time with each test being on the 
order of 15 seconds.  Stauffer and Peppas found that increasing the number of freeze-
thaw cycles to process the PVA hydrogels resulted in a decrease in hydrogel compliance 
[286].  There were no observed changes in hydrogel mass over the short-term creep study 
[286].  Jin et al. estimated viscoelastic parameters for hyaluronate-polyhydroxyethyl 
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acrylate hydrogels by using a 6-element spring and dashpot Voigt model to interpret 
strain data at a constant stress [287].  Time constants were calculated from moduli of 
elasticity and viscosity coefficients given by the Voigt model [287].  They found 
instantaneous elastic modulus values that increased sharply with decreases in hydrogel 
water content.   
 Ravenelle et al. examined the effects of incremental unconfined compression 
steps followed by incremental decompression steps on swollen crosslinked high amylose 
starch tablets [288].  After each step, they found stress relaxation responses that 
resembled Maxwell type behavior, however no comparison was made to any model.  
Tests of permeability showed that water flowed into and out of the hydrogel tablets with 
compression and decompressions steps.  With unconfined compressive fatigue studies on 
PVA/PVP hydrogels, Joshi et al. showed that hydrogel density and water content did not 
change with up to 10 million cycles from 0-15% strain at 5 Hz [136].  Changes in sample 
dimensions after 10 million cycles were attributed to polymer chain rearrangement as the 
water content and density of the polymers were unchanged [136].  Stammen et al. have 
used the changes that occur in PVA hydrogel samples between 2 consecutive loading 
cycles to determine at which strain level the hydrogel begins to undergo plastic 
deformation [131].  With 2 cycles of compression to a common load level, they measured 
the differences in displacement between the 1st and 2nd cycles.  A greater displacement 
was required during cycle 2 to achieve the same load level  In addition, under stroke 
control, they performed a single compression and unloading cycle on the hydrogel 
samples and measured the resulting residual displacements of the samples from the 
preload condition after a one minute recovery period.   The onset of plastic deformation 
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was taken to be the strain level at which the difference in peak loads between cycle 1 and 
cycle 2 or the strain level at with the residual displacement started to increase drastically 
[131].   
 It is surprising to not find more experiments in which the hydrogel water content 
is measured after mechanical testing and compared to control hydrogels.  Bertagnoli et al. 
determined water content of Neudisc nucleus replacement devices after 10 million 
unconfined compressive fatigue cycles [124].  They allowed the hydrogel samples a 14 
day recovery period after mechanical testing before they determined the effect that 
fatigue cycling had on modulus and water content of the hydrogels [124].  For tests of a 
hydrogel material, it would be beneficial to know the water content of the hydrogel both 
immediately after the mechanical test and after a recovery period.  By measuring sample 
height recovery immediately after the test and after a recovery period, one could 
potentially determine whether the hydrogel is deforming and recovering by chain 
rearrangement and relaxation, water flow into and out of the hydrogel, or some 
combination of the two.   
 From the unconfined compression tests that were discussed in Chapter 5, it was 
concluded that hydrogels made from PNIPAAm with 7% PEG grafts and PNIPAAm with 
7% PEG branches were less stiff than hydrogels made from pure PNIPAAm.  However 
after one compression and unloading cycle, the PNIPAAm hydrogels with 7% PEG 
branches showed more elastic recovery than pure PNIPAAm or hydrogels made from 7% 
PEG grafts.  For this study, the effects of repeated compression and unloading cycles on 
the properties of hydrogels made from these three polymer formulations were studied.  
Specifically, the water content and sample height recovery were measured.   
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7.2 Experimental 
 Cylindrical hydrogels were prepared from PNIPAAm, PNIPAAm with 7% PEG 
grafts, and PNIPAAm with 7% PEG branches by the method described in Section 5.2.2.  
The samples were left to swell for 14 days in PBS solution at 37°C because it was shown 
in Chapter 5 that hydrogels prepared from these polymers reached equilibrium swelling 
between 1 and 2 weeks of immersion.  The tests were performed on an Instron Model 
3362 equipped with a water bath containing 37°C PBS shown in Figure 7.1.  Load 
measurements were recorded with a 100N load cell.  From a 0.1N compressive preload, 
each cylindrical sample was compressed to 7 kPa at a strain rate of 100% min-1 and then 
unloaded to the preload condition at the same rate.  This compression/unloading cycle 
was repeated 4 more times for each sample.   
 Upon the completion of the 5th cycle, the recovery of the cylinder height was 
determined by measuring the displacement that the crosshead needed to be moved until 
the preload load condition of 0.1N was reached.  This measurement sample height 
recovery was done immediately after (n=6) and 30 minutes after (n=6) the 5th unloading 
period was completed.  The samples measured 30 minutes after the 5th unloading period 
were left to recover in the PBS bath at 37°C.  After height recovery for each sample was 
determined (either immediately after or 30 minutes after the cycles were completed), the 
mass of the sample (mgel(t)) was promptly measured.  The samples were then dried in a 
vacuum oven.  Upon complete drying, the dry masses of the samples were measured 
(mdry(t)) and a water content percentage was calculated for each sample as was presented 
in Chapter 5. 
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A control group of samples (n=6) for each polymer that had not been mechanically tested 
were also weighed and then dried in a similar manner to determine their water contents. 
For comparison of data sets, Minitab Statistical Analysis Software (Version 
13.30) was used to conducted one-way analysis of variance (ANOVA) tests.  To 
determine statistical significance, a 95% confidence interval (p<0.05) was used.  The p 
value was reported to describe to characterize significance when the confidence interval 
was greater than 95%.   
7.3 Results 
 Representative stress-strain responses for the 5 compression/unloading cycles on 
the three different polymers are shown on the graph in Figure 7.2.  From this graph it is 
difficult to discern the specific cycles.  However it is clear that PNIPAAm hydrogels are 
stiffer than the hydrogels prepared from PNIPAAm with 7% PEG grafts and PNIPAAm 
with 7% PEG branches, in considering the slopes of these curves.  Representative 
mechanical responses for each polymer are shown in Figure 7.3 (PNIPAAm), Figure 7.4 
(PNIPAAm with 7% PEG grafts), and Figure 7.5 (PNIPAAm with 7% PEG branches) 
with responses color coded by cycle number.  Like the unloading responses presented in 
Chapter 5, a zero compressive stress was an indication that the top of the sample had lost 
contact with the crosshead as it returned to its initial position.   For some of the tests, the 
samples stuck to the compression anvils resulting in the generation of a small tensile 
stress as seen in Figure 7.4 as negative stress values.  When this occurred the stress 
eventually returned to zero after the tensile stress became greater than the forces 
responsible for the adhesion and the sample became un-stuck.   
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 Responses for the hydrogels made from PNIPAAm and PNIPAAm with 7% PEG 
grafts were similar.  Each ensuing cycle moved along the strain axis indicating that the 
hydrogel samples deformed to a higher level of strain with each cycle to reach the same 
common stress level (7 kPa).  The compressive stiffnesses (measured from the initial 
slope of the first loading cycle) of the hydrogels prepared with PNIPAAm with 7% PEG 
grafts and PNIPAAm with 7% PEG branches were similar and correlated with the values 
obtained after 15 days of immersion (reported in Chapter 5).   
 There were marked differences between the mechanical responses observed for 
hydrogels made from pure PNIPAAm and PNIPAAM with 7% PEG grafts and hydrogels 
made from PNIPAAm with 7% PEG branches (Figure 7.5).  The strain level at which 7 
kPa of compressive stress was reached for the first compression cycle was greater for 
hydrogels made from branched PEG as the stiffness of these hydrogels is less than those 
of hydrogels made from pure PNIPAAm or PNIPAAm with 7% PEG grafts.  For the 
hydrogels made from PNIPAAm with 7% PEG branches, the differences between the 
maximum strain levels achieved with the 1st and 2nd cycle are significant but far less than 
those observed for hydrogels made from PNIPAAm and PNIPAAm with 7% PEG grafts.  
The maximum strain level achieved with each ensuing cycle are minimal.  
 Cylindrical sample heights, measured immediately after and 30 minutes after the 
5th unloading cycle, were normalized to the maximum deformation each sample achieved 
during the 5th cycle (Figure 7.6).  The ratio recovery represents a fraction of the 
deformation that was recovered.  Normalized sample height recovery was statistically 
higher for hydrogels made from pure PNIPAAm (0.316) than hydrogels made from 
PNIPAAm with 7% PEG grafts (0.241) (p<0.001).  After 30 minutes of recovery, no 
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statistical difference was observed between the height recovery of the hydrogels made 
from pure PNIPAAm (0.705) and hydrogels made from PNIPAAm with 7% PEG grafts 
(0.674) (p>0.05).  Sample height recovery for hydrogels made from PNIPAAm with 7% 
PEG branches immediately after the test (0.713 of the maximum deformation) and after 
30 minutes of recovery (0.875 of the maximum deformation) were significantly higher 
than height recoveries for the other two hydrogels (p<0.001).   
 The water content of the PNIPAAm hydrogels prepared with 7% PEG grafts and 
7% PEG branches measured both immediately after and 30 minutes after the test did not 
change from values measured for control hydrogels for each of these polymers (Figure 
7.7).  The water contents of these control samples reflects the water contents of the 
hydrogels immediately prior to the 5 compression and unloading cycles.   For the pure 
PNIPAAm hydrogels, the water content significantly decreased from 38.3% prior to the 
mechanical test to 32.8% immediately after the test (p<0.002).  However, during a 30 
minute recovery period, the water content of the hydrogels increased back up to 40.6% 
(p<0.001).  There were no statistical differences between the water content of the pure 
PNIPAAm hydrogel immediately prior to the test and after the 30 minute recovery period 
(p>0.05).     
7.4 Discussion 
 With this study, we were able to show the effects of different PEG incorporation 
methods on the mechanical responses of the hydrogel polymers.  The addition of PEG 
resulted in a decrease in stiffness of the hydrogel as was shown in Chapter 5.  This was 
attributed to the entrapment of more water in the hydrogel with the addition of PEG in 
both the grafted and branched forms (Figure 5.9 and Figure 5.11).  However in this 
  156
current study, the non-mechanically tested control hydrogels made from PNIPAAm and 
PEG grafted PNIPAAm showed similar water contents after 14 days of immersion 
(38.3% and 39.2% respectively).  This discrepancy is not understood. 
 Stiffness is only one aspect of the mechanical response that should be considered 
when evaluating the potential of a material to serve as a nucleus pulposus replacement.  
The dimensional recovery a hydrogel replacement should be sufficient so that the 
hydrogel is able to withstand multiple compression and unloading cycles and quickly 
recover its shape.  Sample height recovery measured immediately after the test was 
mainly composed of the elastic response of the hydrogel sample.  In addition to the 
elastic “spring” response of the hydrogel, height recovery measured 30 minutes after the 
test also encompassed the time-dependent “dashpot” effects.  Additional height recovery 
past the 30 minute period is likely minimal.   
 The heights of pure PNIPAAm hydrogels did not quickly or fully recover from 
compressive deformation.  Compressive cycling caused water to be displaced from pure 
PNIPAAm hydrogels.  After the unloaded 30 minute recovery period, water had diffused 
back into the PNIPAAm hydrogels to a level slightly higher than the control samples.   
 PEG grafts were not effective in enhancing the elastic recovery of the PNIPAAm 
hydrogels.  Sample height recovery after 30 minute recovery periods for PEG grafted 
PNIPAAm and pure PNIPAAm hydrogels were similar (70.5% and 67.4% of the 
maximum deformation respectively).  Like PNIPAAm hydrogels, hydrogels prepared 
from PEG grafted PNIPAAm rely solely on physical interactions and entanglements 
between PNIPAAm chains for their stability.  The grafts are only an average of 23 PEG 
repeat units long and would not appreciably increase chain entanglements within the 
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hydrogels.  Mechanical manipulation of PNIPAAm and PEG grafted PNIPAAm 
hydrogels likely resulted in a change in the orientation of the polymer chains and the 
formation of new physical interactions and entanglements.  However, PEG grafts were 
effective in preventing the hydrogel from losing water during the cyclic compression 
tests.  With PEG grafted PNIPAAm hydrogels, the compressive forces that were able to 
push water out of the hydrogel made from pure PNIPAAm were counterbalanced by a 
collection of forces that kept water in the hydrogel.  The main interactions responsible for 
these forces are Hydrogen bonds between water molecules and hydrophilic PEG chains.   
 PEG branches were effective in increasing the water content of PNIPAAm 
hydrogels and holding onto water molecules during the mechanical tests as was seen with 
the PEG grafted PNIPAAm hydrogels.  In addition, PEG branches enhanced the 
dimensional recovery after compressive cycling.  The PEG branched PNIPAAm 
hydrogels only experienced minimal additional deformation after 2 cycles of compression 
and unloading.  The height recovery of PEG branched PNIPAAm hydrogels immediately 
after the mechanical test was about the same as the height recoveries of PNIPAAm and 
PEG grafted PNIPAAm hydrogels after 30 minute recovery periods.  After 30 minutes of 
recovery, the PEG branched PNIPAAm hydrogels regained 87.5% of the maximum 
displacement.  This corresponds to an average 3.4% decrease in sample height as a result 
of the five compression and unloading cycles.  Whether this small deformation is real or 
permanent is unclear.  Residual deformations could be due to the fact that 
preconditioning cycles were not used in this study.   
 PEG branches form covalent linkages between PNIPAAm chains while the pure 
PNIPAAm and PEG branched PNIPAAm hydrogels only have physical interactions and 
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entanglements linking PNIPAAm chains.  The networks that were formed by PEG 
branches were able to elastically deform and recover, almost allowing the hydrogel 
samples to recover to their as original shapes and sizes.   
 Johannessen et al. have shown that compressive fatigue alters the elastic and 
viscoelastic mechanical properties of the sheep intervertebral disc in vitro [289].  
However they found that the mechanical properties of the disc are restored back to their 
original values after an 18 hour recovery period.  Though they did not measure water 
content or dimensional recovery of the disc during these tests, they put forth that the 
recovery of the mechanical properties to pre-fatigue values indicates a re-imbibing of 
fluids back into the disc that had been expelled during compressive cycling.  Changes in 
disc height have been attributed to diurnal fluid flow into and out of the disc [14, 290].  
Though the samples in the current study were only subjected to 5 compression and 
unloading cycles, the dimensional recovery and maintenance of water content of the 7% 
PEG branched hydrogels are promising.  Further experiments on the effects that more 
rigorous mechanical tests have on the hydrogel water content and dimensions are 
warranted.   
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Figure 7.1 Setup for compression testing of hydrogel samples immersed in PBS 
at 37°C  
 
 
 
 
 
 
 
 
 
 
 
 
  160
-1
0
1
2
3
4
5
6
7
8
0 0.05 0.1 0.15 0.2 0.25 0.3
Strain
C
om
pr
es
si
ve
 S
tre
ss
 (k
Pa
) 0% (Pure PNIPAAm)
7% (grafts)
7% (branches)
Molar % PEG 
(Incorporation Method)
 
Figure 7.2 Representative mechanical responses for five compression and 
unloading cycles on hydrogels prepared from PNIPAAm, PNIPAAm 
with 7% PEG grafts, and PNIPAAm with 7% PEG branches 
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Figure 7.3 Representative mechanical responses for five compression and 
unloading cycles on hydrogels prepared from PNIPAAm 
homopolymer 
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Figure 7.4 Representative mechanical responses for five compression and 
unloading cycles on hydrogels prepared from PNIPAAm with 7% 
PEG grafts 
 
 
 
 
 
 
 
 
 
 
 
  163
0
1
2
3
4
5
6
7
8
0 0.05 0.1 0.15 0.2 0.25 0.3
Strain
C
om
pr
es
si
ve
 S
tre
ss
 (k
Pa
) 1 2 3 4 5
Cycle Number
 
Figure 7.5 Representative mechanical responses for five compression and 
unloading cycles on hydrogels prepared from PNIPAAm with 7% 
PEG branches 
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Figure 7.6 Sample height recovery (normalized to the maximum deformation 
achieved during the 5th loading cycle) for the 3 polymers immediately 
after and 30 minutes after 5 compression and unloading cycles 
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Figure 7.7 Water content of the hydrogels made from the 3 polymers 
immediately after and 30 minutes after 5 loading and unloading 
cycles.  Hydrogels that were not mechanically tested were used as a 
control and reflect the water content prior to mechanical testing. 
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8 Conclusion 
• ATR-FTIR and 1H-NMR experiments confirmed the polymerization of pure 
PNIPAAm, PEG grafted PNIPAAm and PEG branched PNIPAAm. 
• Values of intrinsic viscosity increased with increasing concentrations of PEG 
grafts and PEG branches, however to a greater extent with PEG branches.  This is 
due to the fact that addition of PEG branches results in a loosely connected 
network while addition of PEG grafts should only have a limited effect in raising 
the interactions among polymer chains.  The viscosities of the 7% PEG branched 
PNIPAAm polymers ([M]/[I]=200 and [M]/[I]=600) were too high for the method 
to give accurate measurements indicating that these polymers have network-like 
characteristics.  
• Increases in intrinsic viscosity of 7% PEG grafted PNIPAAm hydrogels with 
increasing [M]/[I] ratio indicates that the molecular weight of the polymers can be 
effectively controlled.   
• The Mark-Houwink-Sakurada equation was used to estimate values of vM for the 
PNIPAAm copolymers.  Estimates of vM increased as PEG graft and PEG branch 
concentration increased.  vM  also increased as the [M]/[I] ratio was increased.  
• Most of the copolymers created exhibited LCSTs that fell within the temperature 
range suitable for an injectable soft tissue replacement (25-37°C).  The addition of 
PEG to PNIPAAm imparted more hydrophilicity to the polymer, causing the 
LCST of the solutions to increase.  31% PEG grafted and 31% PEG branched 
copolymers exhibited LCSTs that were too high for the application. 
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• LCST values of the PNIPAAm based polymers tested are not dependent on 
polymer fraction. 
• The method of repeatedly measuring the same sample during swelling study #1 
led to polymer mass loss associated with the measurement technique and not the 
immersion study. 
• PEG branches were more effective than PEG grafts in raising the water content of 
PNIPAAm hydrogels.  The PEG grafted hydrogels have clusters of physically 
associated PNIPAAm chains through interactions and entanglements.  By 
branching the structure, a porous network forms, that can hold onto and entrap 
water.  Hydrogel swelling was not as dependent on the [M]/[I] ratio as PEG 
content or polymer structure (grafts versus branches).   
• Polymer dissolution of the PEG grafted and PEG branched PNIPAAm hydrogels 
does not seem to be dependent on hydrogel composition.  Negative dissolution 
percentages could indicate the uptake of ions from immersion media into the 
hydrogel networks.   
• 1H-NMR showed that the PEG grafted and PEG branched PNIPAAm hydrogels 
were chemically stable over 90 days immersion in PBS.  
• 7% PEG grafted and 7% PEG branched PNIPAAm had compressive modulus 
values between 15-25 kPa.  Cadaver and finite element studies have shown that 
replacing the nucleus with a material having a 50 kPa compressive modulus was 
successful in restoring healthy tension to the annulus layers.  The addition of PEG 
branches to PNIPAAm resulted in a hydrogel that was able to elastically recover 
during unloading from a compression test. 
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• The effect of the osmotic pressure of the nucleus pulposus on PNIPAAm 
copolymer hydrogels could not be observed with the presented study.  Uptake of  
PEG (20K) chains from the media used to simulate the osmotic environment were 
able to penetrate and swell the hydrogels.   
• When subjected to compressive cycling, the heights of pure PNIPAAm and 7% 
PEG grafted PNIPAAm hydrogels did not quickly or fully recover.  The 
dimensional recovery of PEG branched PNIPAAm hydrogels was far superior 
immediately after cyclic compression and after a 30 minute recovery period.    
• Compressive cycling did not change the water content of the 7% PEG branched 
and 7% PEG grafted hydrogels.  Compressive cycling resulted in a loss of water 
in pure PNIPAAm hydrogels that was recovered completely after a 30 minute 
recovery period.   
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9 Novel Contributions 
• Formulated a family of PEG grafted and PEG branched PNIPAAm based 
copolymers with LCST values between room and body temperature.   
• To date, most applications of PNIPAAm polymers have been in non-load bearing 
applications such as the delivery of therapeutic proteins.  In this work, PNIPAAm 
was tailored so that it may serve as a structural soft tissue replacement.   
• Showed that injectable solutions of PNIPAAm copolymers can form hydrogels 
with mass, chemical, and mechanical stability in vitro.   
• Determined the influence that PEG graft concentration, PEG branch 
concentration, and [M]/[I] ratio have on the properties of PNIPAAm hydrogels in 
vitro. 
• Increased the water content and elastic recovery of pure PNIPAAm hydrogels by 
incorporating PEG branches into a PNIPAAm polymer structure.   
• Designed a protocol to measure hydrogel mechanical properties, dimensional 
recovery after compressive cycling, and the effects of this cycling on the water 
content of the hydrogel.  
• Discovered that PEG grafts and PEG branches allow PNIPAAm hydrogels to 
retain water during compressive cycling while water is exuded from a PNIPAAm 
hydrogel structure as the result of compressive cycling.   
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